{"Title": ["3 Pot Stocks Worth a Second Look", "Here's Why Arena Pharmaceuticals Jumped Higher Today", "Noteworthy Thursday Option Activity: PLCE, VEEV, ARNA", "BUZZ-U.S. STOCKS ON THE MOVE-ARCA Biopharma, Aerpio Pharma, Triumph Group", "BUZZ-U.S. STOCKS ON THE MOVE-Blue Hat, ARCA Biopharma, Aerpio Pharma", "Health Care Sector Update for 05/28/2020: PHAS, ARNA, IOVA", "BUZZ-U.S. STOCKS ON THE MOVE-Aerpio Pharma, Arena Pharma, Triumph Group", "Health Care Sector Update for 05/18/2020: JNJ,VIR,ARNA,BLUE", "3 Pot Stocks Worth a Second Look", "Arena Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ARNA", "Arena Pharmaceuticals Inc (ARNA) Q1 2020 Earnings Call Transcript", "Look Under The Hood: VBK Has 12% Upside", "EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q1 Earnings Report", "Arena Pharmaceutical Q1 20 Earnings Conference Call At 4:30 PM ET", "Interesting ARNA Put And Call Options For June 5th", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 4/19/2020", "Health Care Sector Update for 05/18/2020: VIR,ARNA,BLUE", "3 Reasons Medical Marijuana Is a Better Long-Term Investment Than Recreational Pot", "Arena Pharmaceuticals (ARNA) Shares Cross Above 200 DMA", "ARNA August 21st Options Begin Trading", "ARNA May 29th Options Begin Trading", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 3/15/2020", "Interesting ARNA Put And Call Options For May 1st", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/28/2020", "Validea's Top Five Healthcare Stocks Based On David Dreman - 4/19/2020", "EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q4 Earnings Report", "Arena Pharmaceutical Q4 19 Earnings Conference Call At 4:30 PM ET", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/16/2020", "FDA Asks That Weight Loss Drug Belviq Be Pulled From the Market", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/13/2020", "Bullish Two Hundred Day Moving Average Cross - ARNA", "Surprising Analyst 12-Month Target For JKL", "Arena Pharmaceuticals Inc (ARNA) Q4 2019 Earnings Call Transcript", "Arena Pharma To Present At J.P. Morgan Conference; Webcast At 1:00 PM ET", "Noteworthy Monday Option Activity: ARNA, MYGN, ICPT", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 12/15/2019", "Arena Pharmaceuticals Inc (ARNA) Q3 2019 Earnings Call Transcript", "Health Care Sector Update for 11/08/2019: ARWR,IOVA,GH,ARNA", "Health Care Sector Update for 11/08/2019: IOVA,GH,ARNA", "Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 1/19/2020", "Noteworthy Wednesday Option Activity: RTN, ARNA, TEAM", "ARNA November 29th Options Begin Trading", "Interesting ARNA Put And Call Options For November 22nd", "Arena Pharma To Present At Cantor Global Conference; Webcast At 3:00 PM ET", "Arena Pharmaceuticals is Now Oversold (ARNA)", "Noteworthy Friday Option Activity: MRK, ABT, ARNA", "First Week of ARNA April 2020 Options Trading", "EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q3 Earnings Report", "Interesting ARNA Put And Call Options For September 27th", "Noteworthy Thursday Option Activity: ARNA, TWLO, AVLR", "Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript", "EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q2 Earnings Report", "Arena Pharmaceutical Q2 19 Earnings Conference Call At 4:30 PM ET", "Strange: Bullish ARNA Analysts Actually See -3.78% Downside", "First Week of ARNA September 20th Options Trading", "Arena Pharmaceutical To Present At Wells Fargo Conference ; Webcast At 8:30 AM", "Here's Why United Therapeutics Fell 18.1% in May", "Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript", "EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q1 Earnings Report", "Arena Pharmaceutical Needham Healthcare Conference At 12:00 PM ET", "United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates", "Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues", "Arena Pharmaceuticals Inc (ARNA) Q4 2018 Earnings Conference Call Transcript", "ARNA Crosses Above Average Analyst Target", "Arena Pharma. To Participate In J.P. Morgan Healthcare Conference At 12:30 PM ET", "ARNA February 2019 Options Begin Trading", "Why Is Arena Pharmaceuticals (ARNA) Up 8.1% Since Last Earnings Report?", "ARNA Crosses Below Key Moving Average Level", "Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal", "My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy", "Arena (ARNA) Out-Licenses Rights to PAH Drug, Stock Up 22%", "5 Clinical Stage Biotech Stocks to Buy", "Health Care Sector Update for 11/16/2018: ARNA,UTHR,SGEN,HCM", "Why Arena Pharmaceuticals Stock Is Soaring Today", "Thursday's ETF Movers: XBI, ITB", "Mid-Day Market Update: Smart & Final Stores Rises Following Strong Q3 Earnings; Remark Holdings Shares Drop", "Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today", "Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Expectations", "Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today", "Health Care Sector Update for 11/16/2018: AMED,ARNA, SGEN,HCM", "Health Care Sector Update for 11/15/2018: ARNA,UTHR,QURE,ABIO", "Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales", "Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for", "Arena (ARNA) Posts Favorable Top-Line Data on Pain Candidate", "Why Is Arena Pharmaceuticals (ARNA) Up 7.4% Since Last Earnings Report?", "Arena Pharmaceuticals (ARNA) Shares Cross Above 200 DMA", "7 Stocks Set for Monster Growth in 2018", "Health Care Sector Update for 11/15/2018: ARNA, UTHR, QURE, ABIO", "Health Care Sector Update for 11/15/2018: ARNA,UTHR,QURE,ABIO", "Arena Pharmaceuticals (ARNA) Beats on Q3 Earnings and Sales", "What's in the Cards for Arena (ARNA) This Earnings Season?", "Notable Thursday Option Activity: GS, ARNA, LFGR", "Arena Pharmaceuticals (ARNA) Up 15.1% Since Earnings Report: Can It Continue?", "7 Stocks Set for Monster Growth in 2018", "Arena Pharmaceuticals (ARNA) Q1 Loss Wider Than Expected", "Arena Pharmaceuticals Becomes Oversold (ARNA)", "What's in the Cards for Arena (ARNA) This Earnings Season?", "3 Top Biotech Stocks to Buy Right Now", "Arena Pharmaceuticals (ARNA) Up 7% Since Earnings Report: Can It Continue?", "This Obesity Drugmaker Just Made a Comeback While Another Declared Bankruptcy", "3 Biotech Stocks That Skyrocketed This Week: Are They Buys?", "Arena Pharmaceuticals Takes Aim at Celgene", "Arena Pharmaceuticals (ARNA) in Focus: Stock Moves 10.7% Higher", "Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More", "What's in the Cards for Arena (ARNA) This Earnings Season?", "3 Top Biotech Stocks to Buy Right Now", "Company News For Mar 21, 2018", "Why Whiting Petroleum, Arena Pharmaceuticals, and First Majestic Silver Jumped Today", "Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday", "Mid-Day Market Update: Crude Oil Up 2.5%; Arena Pharmaceuticals Shares Spike Higher", "Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal", "Pre-Market Most Active for Mar 22, 2018 : TVIX, QQQ, FB, MU, NOK, ARNA, BAC, BABA, SQQQ, DB, MFGP, SBGL", "Pre-Market Most Active for Mar 20, 2018 : FB, TVIX, QQQ, EEP, MU, ORCL, ARNA, NS, BPL, MFGP, SBGL, ERIC", "Arena Pharmaceuticals Takes a Big Step Forward", "What Happened in the Stock Market Today", "Mid-Afternoon Market Update: MuleSoft Gains Following Report Of Takeover Interest From Salesforce; Proteostasis Therapeutics Shares Slide", "Why Arena Pharmaceuticals Shares Are Rocketing 31.6% Higher Today", "Arena Pharmaceuticals Becomes Oversold (ARNA)", "Arena Pharmaceuticals (ARNA) Q4 Earnings Beat, Sales Down Y/Y", "Mid-Morning Market Update: Markets Gain; Oracle Shares Fall Following Q3 Results", "Arena Pharmaceuticals (ARNA) Q4 2017 Earnings Conference Call Transcript", "Arena (ARNA) Posts Narrower-Than-Expected Q4 Loss, Shares Up", "Orexigen Plummets on Filing of Chapter 11 of Bankruptcy Code", "Health Care Sector Update for 03/14/2018: KOOL, ARNA, QURE, VYGR, BRKR", "Notable Wednesday Option Activity: YELP, ARNA, NDAQ", "Pre-Market Earnings Report for March 14, 2018 : TSG, SIG, ARNA, VYGR, SRLP, EXPR, VRA, CLSD, TGLS, CUI, EVLV, ICON", "What's in the Cards for Arena (ARNA) This Earnings Season?", "Options Traders Expect Huge Moves in Arena Pharmaceuticals (ARNA) Stock", "Commit To Buy Arena Pharmaceuticals At $30, Earn 19.5% Annualized Using Options", "7 Stocks Set for Monster Growth in 2018", "Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter", "3 Top Obesity-Drug Stocks to Consider Buying Now", "7 Stocks Set for Monster Growth in 2018", "Surprising Analyst 12-Month Target For PBE", "Three Interviews From the J.P. Morgan Healthcare Conference", "We Did The Math DWAQ Can Go To $119", "Here's What Pushed Arena Pharmaceuticals, Inc. Up 10.6% in November", "Arena (ARNA) Completes Enrolment in Etrasimod Phase II Study", "Arena Pharmaceuticals (ARNA) Q3 Loss Widens Y/Y, Sales Beat", "The Single Event That Rocketed Arena Pharmaceuticals, Inc. Higher by 10% in October", "What's in the Cards for Arena (ARNA) This Earnings Season?", "Do This 1 Thing and Lower Your Risk for 13 Types of Cancer", "Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September", "Orexigen Struggles as Contrave Commercialization Costs Rise", "This Biotech Craters 70% On Late-Stage Alzheimer's Drug Failure", "Intercept Pharmaceuticals Inc (ICPT) Stock Dives on Drug Warning", "J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use", "Arena Pharmaceuticals (ARNA) Down 1.5% Since Earnings Report: Can It Rebound?", "The 1 Very Clear Reason Arena Pharmaceuticals, Inc. Skyrocketed 41% in July", "Arena Pharmaceuticals (ARNA) Q2 Loss Wider than Expected", "Will Expenses Hit Envision Healthcare (EVHC) Q2 Earnings?", "Orexigen's (OREX) Contrave Sales Improving on Promotions", "Sucampo (SCMP) Q2 Earnings & Revenues Beat Estimates, Up Y/Y", "BioMarin (BMRN) Q2 Loss Narrows, Sales Surpass Estimates", "Can Myriad Genetics (MYGN) Spring a Surprise in Q4 Earnings?", "Can Jazz Pharma (JAZZ) Spring a Surprise in Q2 Earnings?", "Inovio (INO) Q2 Earnings: What Lies Ahead for the Stock?", "What's in Store for Puma (PBYI) this Earnings Season?", "What's in the Cards for Kite Pharma (KITE) in Q2 Earnings", "Mylan (MYL) to Report Q2 Earnings: What's in the Cards?", "Can CVS Health (CVS) Pull a Surprise this Earnings Season?", "What's in the Cards for Celldex (CLDX) this Earnings Season?", "Will ACADIA (ACAD) Pull Off a Surprise this Earnings Season?", "GW Pharmaceuticals (GWPH) Q3 Earnings: What Lies in Store?", "Can Mallinckrodt (MNK) Deliver a Beat this Earnings Season?", "What's in the Cards for Adverum (ADVM) this Earnings Season?", "What's in Store for Arena (ARNA) this Earnings Season?", "Can Ligand (LGND) Pull a Surprise This Earnings Season?", "What's in the Cards for Merrimack (MACK) in Q2 Earnings?", "AstraZeneca (AZN) Beats on Q2 Earnings, Falls on Failed Study", "These 3 Stocks Have Jumped 60% in a Single Month", "What's in the Cards for Geron (GERN) this Earnings Season?", "Top Ranked Momentum Stocks to Buy for July 24th", "Quintiles IMS: A Novel Way To Invest In Biopharma", "Repros (RPRX) Q2 Earnings: What's in Store for the Stock?", "Top Ranked Momentum Stocks to Buy for July 14th", "Why Arena Pharmaceuticals (ARNA) Could Be Positioned for a Surge", "Mid-Day Market Update: Yandex Jumps Following Announcement Of Deal With Uber; Amicus Therapeutics Shares Drop", "Pre-Market Most Active for Jul 13, 2017 : YNDX, FOLD, SNAP, MT, ALDR, ARNA, TEF, QAT, DAL, TGT, QQQ, TEVA", "Company News for July 12, 2017", "Arena Announces Secondary Stock Offering of 150M Shares", "Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal", "Arena Announces Secondary Stock Worth $150M (revised)", "Top Ranked Momentum Stocks to Buy for July 14th", "Mid-Day Market Update: Halcon Resources Jumps After Announcing Sale of Williston Basin Assets; Shiloh Industries Shares Slide", "Arena's Ralinepag Positive in Phase II PAH Study, Shares Up", "Mid-Morning Market Update: Markets Mostly Flat; PepsiCo Profit Tops Expectations", "Why Arena Pharmaceuticals Stock Is Bolting Higher Today", "Stock Futures Turn Lower on Oil-Related Sell-Off in Europe", "Pre-Market Most Active for Jul 11, 2017 : FOLD, HK, SNAP, SHPG, GTY, OCUL, ARNA, RCII, PSO, PEP, WLL, QQQ", "E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day", "3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Barracuda Networks Inc (CUDA) and Arena Pharmaceuticals, Inc. (ARNA)", "What Happened in the Stock Market Today", "Close Update: Dow Flat as Senate Recess-Delay Offsets Email Sell-Off", "Health Care Sector Update for 07/11/2017: OCUL,ARNA,NEOT", "Here's Why Arena Pharmaceuticals (ARNA) Stock is Skyrocketing Today", "Mid-Afternoon Market Update: Crude Oil Up 1.5%; VOXX International Shares Plummet", "Health Care Sector Update for 07/11/2017: FOLD,ARNA,NEOT", "Best Buy Co Inc (BBY) Stock and Retail Got Whacked. Here\u2019s How to Trade.", "3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Barracuda Networks Inc (CUDA) and Arena Pharmaceuticals, Inc. (ARNA)", "Are Options Traders Betting on a Big Move in Arena Pharmaceuticals (ARNA) Stock?", "4 Marijuana Stocks Looking to Combat the Opioid Epidemic", "Arena Ends Study on Extended Release Formulation of PAH Drug", "Mid-Day Market Update: Bed Bath & Beyond Drops Following Disappointing Earnings; Synchronoss Technologies Shares Surge", "Mid-Morning Market Update: Markets Mostly Flat; BlackBerry Sales Miss Views", "Health Care Sector Update for 07/07/2017: CNAT,NVO,ARNA,DXTR", "Why Arena Pharmaceuticals (ARNA) Could Be Positioned for a Surge", "Strength Seen in Arena Pharmaceuticals (ARNA): Stock Up 5.4%", "Mid-Afternoon Market Update: Fang Drops After Q1 Results; Invivo Therapeutics Shares Surge", "Monday's ETF Movers: XBI, GDXJ", "Why Is Arena (ARNA) Up 15.1% Since the Last Earnings Report?", "5 Reasons Why VIVUS (VVUS) Stock Should Be in Your Portfolio", "Better Know a Marijuana Stock: Arena Pharmaceuticals", "The 3 Best Obesity-Drug Stocks to Buy in 2017", "Here's Why Arena Pharmaceuticals Rose as Much as 18.3% Today", "Arena Pharmaceuticals (ARNA) Posts Q1 Loss, Revenues Down", "Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store?", "Arena Pharma (ARNA) Down After Underwritten Public Offering", "Why Is Arena Pharmaceuticals (ARNA) Down 11.3% Since the Last Earnings Report?", "2 Marijuana Stocks That Rocketed Higher by a Double-Digit Percentage Last Week", "Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates", "Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop", "Tuesday Sector Laggards: Shipping, Drugs", "Why Arena Pharmaceuticals Stock Slimmed Down in March", "New Strong Sell Stocks for April 6th", "Arena Pharmaceuticals (ARNA) Posts Q4 Earnings, Revenues Up", "Buy Facebook Inc (FB) Stock as It Steals Snap Inc\u2019s (SNAP) Thunder", "Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet", "Why Arena Pharmaceuticals Stock Is Surging Higher Today", "After-Hours Earnings Report for March 14, 2017 : HTHT, AKAO, CLDX, FOGO, NPTN, ARNA, CCXI, KURA, DRRX, CHMI, CNXR", "Arena Pharmaceuticals (ARNA) Q4 Earnings: What to Expect?", "Why Arena Pharmaceuticals Stock Sank in 2016", "VIVUS Licenses Rights to PAH Drugs from Selten Pharma", "Vertex Pharma Issues Disappointing 2017 Orkambi Outlook", "Puma (PBYI) Expands Study Cohort for Lead Candidate PB272", "3 Stocks to Watch on Wednesday: Bank of America Corp (BAC), Arena Pharmaceuticals, Inc. (ARNA) and Fogo De Chao Inc (FOGO)", "Biogen Licenses Amunix's XTEN Technology for Factor IX Drug", "Health Care Sector Update for 01/05/2017: ARNA,ETRM,AEZS", "Arena, Eisai Modify Marketing & Supply Agreement for Belviq", "Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III", "Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.", "Bristol-Myers Extends Deal with Five Prime Therapeutics", "Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained", "Genocea Stock Up on Positive Genital Herpes Infections Data", "Alexion (ALXN): Will the Stock Continue to Suffer in 2017?", "Allergan Natrelle Inspira Breast Implants Approved in the U.S.", "Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?", "Sanofi (SNY) Closes Business Exchange Deal with Boehringer", "VIVUS (VVUS): Will Qsymia & Stendra Sales Improve in 2017?", "Tax-Loss Selling: 3 Stocks to Dump Right Now", "Arena (ARNA) Q3 Loss Lower than Expected, Revenues Rise", "Clovis Declares Pricing of Upsized Offering of Common Stock", "Why Arena Pharmaceuticals Is Finally Showing Some Signs of Life", "Arena (ARNA) Beacon Discovery to Boost Research Platform", "Actelion (ALIOF) Uptravi Approved for PAH in Switzerland", "Arena's (ARNA) Q2 Loss Narrower, Revenues Increase Y/Y", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 50.0% Follow-Through Indicator, 12.6% Sensitive", "Arena (ARNA) Q2 Earnings: What's in Store for the Stock?", "Company News for July 20, 2016", "Arena Pharmaceuticals Shed Even More Weight in October", "Health Care Sector Update for 07/14/2016: RARE,ARNA,RNVA", "Health Care Sector Update for 07/14/2016: VRX,ARNA,RNVA", "Arena (ARNA) to Cut 73% Workforce, Shifts Focus to Pipeline", "3 Stocks to Watch on Friday: Arena Pharmaceuticals, Inc. (ARNA), Micron Technology, Inc. (MU) and Tesla Motors Inc (TSLA)", "Health Care Sector Update for 07/01/2016: ARNA,ARRY,MSLI", "Orexigen Stock Gains More than 50% on Markman Hearing", "Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue?", "Health Care Sector Update for 07/19/2016: ARNA,CERU,SCLN", "Health Care Sector Update for 07/14/2016: RARE,ARNA,RNVA", "Health Care Sector Update for 07/14/2016: VRX,ARNA,RNVA", "Arena (ARNA) to Cut 73% Workforce, Shifts Focus to Pipeline", "Drug Stocks Reporting Early Next Week: TEVA, ARNA & More", "Arena (ARNA) Q1 Earnings: What's in Store for the Stock?", "New Strong Sell Stocks for April 21st", "New Strong Sell Stocks for April 13th", "The Little-Known Reason Arena Pharmaceuticals Could Be a Winner", "Mid-Morning Market Update: Markets Open Higher; Alcoa Revenue Misses Views", "Stock Futures Buoyed by Higher Oil, Shrugging Off Downbeat Alcoa Earnings", "Mid-Afternoon Market Update: Crude Oil Up 4.5%; Horizon Pharma Shares Tumble", "Arena Pharmaceuticals, Inc. Rides Celgene's Coattails to Big Gains in March", "New Strong Sell Stocks for April 7th", "Biotech Investing Guide: 3 Stocks to Buy and 3 to Avoid", "New Strong Sell Stocks for March 8th", "Arena (ARNA) Gains, Pain Drug Positive in Early Stage Study", "Arena's (ARNA) Q4 Loss Narrower but Revenues Fall Short", "Will Arena (ARNA) Post a Narrower-than-Expected 4Q Loss?", "Here's Why Arena Pharmaceuticals Lost 17% of Its Value in January", "Arena, Boehringer Ingelheim Ink Deal, Schizophrenia in Focus", "Genomic Health Down on Bleak Preliminary Q4, '15 Results", "Myriad Genetics: Urologic Cancer Assays Positive in Trials", "Arena Pharmaceuticals Ends 2015 On a Sour Note: Can It Recover in 2016?", "New Strong Sell Stocks for March 4th", "Arena's (ARNA) Q4 Loss Narrower but Revenues Fall Short", "Teva/Active Biotech Halt High Doses of Laquinimod for MS", "Pfizer & Merck KGaA Partner with Syndax for Ovarian Cancer", "Pluristem Therapeutics (PSTI) in Focus: Stock Rises 14.1%", "The Worst 3 Biotech Stocks for 2016", "Anika (ANIK) Starts Enrolment in Phase III HyaloFast Study", "CEL-SCI Corp (CVM) Shows Strength: Stock Moves Up 8.3%", "New Strong Buy Stocks for December 29th", "Actelion's Uptravi Approved in the U.S. for PAH Treatment", "New Strong Buy Stocks for December 22nd", "New Strong Buy Stocks for December 18th", "New Strong Buy Stocks for December 14th", "Why Arena Pharmaceuticals (ARNA) Could Beat Earnings Estimates Again", "Orexigen Therapeutics' Stock Dropped 28% in November: Can It Recover?", "Epizyme's Tazemetostat IND Application Accepted for DLBCL", "New Strong Buy Stocks for December 7th", "Orexigen Therapeutics, Inc.'s Stock Loses Weight on Downgrade", "Why Arena Pharmaceuticals, Inc. Bulked Up in November", "New Strong Buy Stocks for December 3rd", "Why Axovant Sciences Skyrocketed 56% in November", "Can the Rally in Arena Pharmaceuticals (ARNA) Shares Continue?", "Here's Why Arena Pharmaceuticals' Stock Briefly Spiked Today", "Bluebird Bio Crashes After Clinical Trial Update", "Arena (ARNA)/Eisai's Belviq XR NDA Accepted for Review", "How Arena Pharma (ARNA) Stock Stands Out in a Strong Industry", "Why Ambarella, Arena Pharmaceuticals, and ITC Holdings Jumped Today", "New Strong Buy Stocks for November 23rd", "3 Dangerous Stocks", "Arena 3Q Loss Narrower-Than-Expected, Belviq in Focus", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 42.9% Follow-Through Indicator, 12.3% Sensitive", "New Strong Buy Stocks for December 1st", "Why Orexigen Therapeutics, Inc.'s Stock Is Losing Weight Today", "3 Things You Never Knew About Medicare", "Here's Why Arena Pharmaceuticals, Inc. Is Struggling Today", "Will Arena's (ARNA) Q3 Loss be Narrower-than-Expected?", "What's Behind Arena Pharmaceuticals' Volatility Lately?", "Why Zafgen Plummeted Today", "3 Investing Myths, Debunked!", "After-Hours Earnings Report for November 10, 2015 : DOX, KGC, HTHT, EXEL, INGN, NVGS, PNNT, OPWR, ARNA, HCKT, BOOT, EVDY", "2 Questions Investors Need to Ask About Biogen's Latest Deal", "Arena Pharmaceuticals Lost a Third of Its Value in August -- Here's Why", "3 Battleground Biotech Stocks I Would Avoid at All Costs", "Arena Pharmaceuticals (ARNA) Rises: Stock Adds 5.7% in Session", "The 3 Most Disappointing Drug Launches of All Time", "Bull Or Bear? Biotech's Post-Earnings Buys and Sells", "Arena Pharmaceuticals' Belviq Sales Are Better Than They Appear (But They're Still Not Great)", "Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?", "Arena Pharmaceuticals Slims Down After Its Q2 Report", "Is a Surprise Coming for Arena Pharmaceuticals (ARNA) This Earnings Season? - Tale of the Tape", "Will Arena Pharmaceuticals (ARNA) Surprise Q2 Earnings? - Analyst Blog", "Celgene Buys Receptos. Is Arena Pharmaceuticals Next?", "Mid-Morning Market Update: Markets Mostly Higher; Bank Of America Tops Q2 Views", "Obesity Statistics Take a Wrong Turn in This Latest Study", "3 Biotech Stocks That I Won't Buy", "Arena Pharmaceuticals 2Q Loss Narrower-Than-Expected - Analyst Blog", "Orexigen Therapeutics, Inc. Goes From Biotech Beauty to Dreadful Drugmaker", "Which of These Growth Stocks Is Most Worthy of Your Money?", "Why Shares of Orexigen Therapeutics, Inc. Cratered Today", "Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected - Analyst Blog", "Why It's Lights Out for Orexigen Therapeutics, Inc.", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 42.9% Follow-Through Indicator, 11.2% Sensitive", "Will Arena Pharmaceuticals (ARNA) Surprise this Earnings? - Analyst Blog", "Obesity Drugs: Stocks to Watch", "Arena Pharmaceuticals Inc.'s Plan to Win the Obesity Drug War", "Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog", "Zacks Rank #5 Additions for Tuesday - Tale of the Tape", "3 Promising Small-Caps Under $10 You Can Buy Right Now", "3 Promising Healthcare Stocks Under $10", "Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog", "The Best Stock to Invest in Obesity Drugs", "Health Care Sector Update for 04/29/2015: ARNA,ONCY,IG", "Arena Pharmaceuticals Up on Belviq's New Patent Approval - Analyst Blog", "Calls look to ride Arena Pharma", "ARNA Crosses Below Key Moving Average Level", "Biotech Stocks: 2 to Avoid, 1 to Buy", "Zacks Rank #5 Additions for Thursday - Tale of the Tape", "Too Good to Be True? Proceed With Caution on These 2 Biotechs", "After Hours Most Active for Mar 12, 2015 : CY, INTC, PFE, F, CSCO, FXCM, BAC, ARAY, ARNA, WMB, AXP, NVDA", "Health Care Sector Update for 04/10/2015: ARNA, VRTX, ANIP", "Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog", "Could This Surprising Drug Stop Heart Attacks Before They Happen?", "Why Orexigen Therapeutics, Inc. Stock Exploded Higher", "Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog", "Why Arena Pharmaceuticals, Inc. Burst Today", "Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 42.9% Follow-Through Indicator, 10.8% Sensitive", "Zacks Rank #5 Additions for Wednesday - Tale of the Tape", "Orexigen Therapeutics, Inc. Gives the Skinny on Its Drug Launch", "ARNA Crosses Above Key Moving Average Level", "Don't Worry About Orexigen's Obesity Drug EU Approval", "Forget About Ebola Stocks and Invest in This Instead", "Why Arena Pharmaceuticals, Inc. Shares Jumped 24% in January", "Despite the CDC's Best Efforts, This Disease Just Hit Record Levels", "Newly Approved Weight Loss Method Works by Tricking Your Brain", "Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog", "Mid-Day Market Update: U.S. Stocks Surge; Netflix Shares Jump On Upbeat Earnings", "Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations", "Pre-Market Most Active for Jan 21, 2015 : SUNE, UL, SNE, RBS, NFLX, ALNY, ARNA, MTU, TVIX, AAPL, BAC, QCOM", "Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher", "Forget Pills! Could This Device Put an End to Obesity in America?", "Arena Pharmaceuticals Doses for Cardiovascular Study - Analyst Blog", "Can the Uptrend Continue for Arena Pharma (ARNA)? - Tale of the Tape", "Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog", "Why VIVUS, Inc. Stock Descended 14% in December", "Pre-Market Most Active for Jan 9, 2015 : SAN, MPW, QQQ, TVIX, BAC, CNAT, XIV, ALU, AAPL, ARNA, SKM, PBR", "History Suggests MannKind Corporation's Afrezza Could Already Be Doomed", "ARNA February 27th Options Begin Trading", "Pre-Market Most Active for Jan 8, 2015 : ALU, BIND, PBR/A, SAN, PBR, TVIX, XIV, BAC, ABEV, ARNA, AAPL, SIRI", "Arena Pharmaceuticals Soars on Positive Study Results - Analyst Blog", "Arena Pharmaceuticals Inc.'s Phase 1 Data is Worth $550 Million!?", "Arena Pharmaceuticals (ARNA) in Focus: Stock Falls 5.7% - Tale of the Tape", "Why Shares of Arena Pharmaceuticals, Inc. Skyrocketed Today", "Health Care Sector Update for 01/07/2015: RPTP, ARNA, CASM", "Mid-Afternoon Market Update: Dow Jumps Over 200 Points After Fed Minutes; RPM Shares Drop On Downbeat Results", "Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline", "Why Arena Pharmaceuticals, Inc. Stock Slumped 17% in December", "The Newest FDA-Approved Obesity Drug Is Also the Oldest", "3 Stocks Poised for Eye-Popping Gains in 2015", "Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates", "Novo Nordisk's Saxenda Gets FDA Nod, Launch in 1H15 - Analyst Blog", "New Obesity Drug Available Soon", "This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year", "Could This Company Follow in Dendreon's Footsteps?", "Why Orexigen Therapeutics, Inc. Stock Rocketed 43% Higher in November", "For This Obesity Drug, Europe Trumps the U.S.", "Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Tale of the Tape", "3 Biotech Stocks I Don't Want for Christmas", "Why Orexigen Therapeutics, Inc. Stock Skyrocketed", "Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows - Analyst Blog", "Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog", "Could Arena Pharmaceuticals Inc. Be Running Out of Money?", "3 Biotech Stocks Near 52-Week Lows Worth Buying", "The 1 Biotech Stock I'm Definitely Not Buying", "Why Is Sanofi Betting on MannKind Corporation's Afrezza?", "Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?", "Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5% - Tale of the Tape", "NASDAQ Biotech Top Performers (Pre-Open September 19)", "3 Biotechs Investors Should Watch", "Why VIVUS, Inc. Is Today's Best Biotech Stock", "5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know", "2 New Diet Drugs Coming Soon?", "Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr", "Is VIVUS Inc. a Short Sell?", "Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014", "Arena Pharmaceuticals' APD811 Gets Orphan Drug Status - Analyst Blog", "3 Simple Ways to Invest Like George Soros", "Biotech Investing: 3 Ways You're Doing It Wrong", "Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog", "September 12th Options Now Available For Arena Pharmaceuticals (ARNA)", "Sector Update: Health-care Stocks Flat Pre-Market", "FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug", "Arena Pharmaceuticals' Pain Candidate Gets New U.S. Patent - Analyst Blog", "Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog", "Company News for July 08, 2014 - Corporate Summary", "Arena Pharmaceuticals (ARNA) in Focus: Stock Slumps 9.4% - Tale of the Tape", "Monday's ETF with Unusual Volume: IYY", "Monday's ETF Movers: FM, XBI", "Bullish Two Hundred Day Moving Average Cross - ARNA", "Sector Update: Health Care", "July 3rd Options Now Available For Arena Pharmaceuticals (ARNA)", "Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog", "FDA Panel to Review Novo Nordisk's Victoza 3mg - Analyst Blog", "First Week of ARNA August 16th Options Trading", "Arena Slides on Wider Q1 Loss, Misses Ests - Analyst Blog", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 50.0% Follow-Through Indicator, 11.9% Sensitive", "After-Hours Earnings Report for May 12, 2014 : MCK, TRQ, BWC, RAX, PGH, MNKD, TRAK, CVG, PKY, ARNA, DXPE, PDLI", "July 25th Options Now Available For Arena Pharmaceuticals (ARNA)", "ARNA Crosses Below Key Moving Average Level", "Interesting ARNA Put And Call Options For May 30th", "Interesting ARNA Put And Call Options For May 23rd", "ARNA Crosses Below Key Moving Average Level", "Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog", "Company news for March 03, 2014 - Corporate Summary", "Interesting ARNA Put And Call Options For June 6th", "Earnings Reaction History: Arena Pharmaceuticals, Inc., 60.0% Follow-Through Indicator, 4.7% Sensitive", "#PreMarket Primer: Friday, February 14: A Turnaround", "Sector Update: Healthcare Shares Flat Pre-Market; Regeneron Rises 4% on Phase 3 Trial of Eylea", "Sector Update: Healthcare", "Arena Pharmaceuticals (ARNA) in Focus: Stock Rallies 7.2% - Tale of the Tape", "FDA Action Date for Orexigen's Contrave - Analyst Blog", "Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Surges 19.7% - Tale of the Tape", "Arena Posts Wider Loss, Misses Ests - Analyst Blog", "Arena Pharmaceuticals (ARNA) Worth a Look: Stock Surges 10.6% - Tale of the Tape", "Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog", "Sector Update: Healthcare", "VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog", "Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape", "Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape", "Arena to Double Belviq Sales Force - Analyst Blog", "VIVUS Shares Up Marginally Post Sanofi Deal - Analyst Blog", "Obesity Drug Makers Vivus and Arena Just Can't Seem to Lighten Up", "Update on Orexigen's Contrave - Analyst Blog", "Stock Upgrades: Apple, Hain Celestial, and Signet Jewelers", "Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares Jump", "What's Weighing on Obesity Drug Makers Vivus and Arena?", "VIVUS' Hopes Tied to Qsymia - Analyst Blog", "Update on Arena/Eisai's Belviq - Analyst Blog", "Mid-Morning Market Update: Markets Slip; Citigroup Profit Misses Estimates", "Obesity Drug Makers Vivus and Arena Just Can't Seem to Lighten Up", "VIVUS Gets a New CEO - Analyst Blog", "Pipeline at Arena Pharma Advances - Analyst Blog", "Loss Widens at VIVUS - Analyst Blog", "Arena Pharma's Q2 Earnings Soar - Analyst Blog", "Pre-Market Most Active for Aug 1, 2013 : DELL, JCP, BAC, SUNE, FB, ALU, SXC, BCRX, XOM, ARNA, MYL, HALO", "Arena Pharma, CY Biotech Unite for Belviq - Analyst Blog", "After Hours Most Active for Sep 12, 2013 : SO, C, MO, DOW, WAG, RIO, ARNA, INTC, ULTA, QQQ, MSFT, SPLK", "Better Access to VIVUS' Qsymia - Analyst Blog", "Arena Seeks Canadian Approval for Belviq - Analyst Blog", "Healthcare Stocks Inching Lower; Weight Loss Drug-Makers Climbing After AMA Labels Obesity as Disease", "Sector Update: Healthcare", "Pre-Market Most Active for Jun 12, 2013 : CTB, NCT, WDAY, BAC, VOD, S, NOK, GT, GRFS, ARNA, SIRI, CLVS", "Market Wrap for Tuesday, May 28: Bull Run Continues as Economic Data Sparks Another Rally", "ARNA Sheds Light on Belviq Launch - Analyst Blog", "VIVUS Appoints New CEO - Analyst Blog", "Arena Pharma Narrows Loss - Analyst Blog", "Mid-Morning Market Update: Markets Surge On Jobs Data, Dow Breaks 15,000 for the First Time in History", "Pre-Market Most Active for May 3, 2013 : CETV, BAC, ARNA, SPIL, FB, QQQ, AIG, NVS, DB, SIRI, NOK, ABX", "Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data", "After Hours Most Active for May 2, 2013 : QQQ, AIG, LNKD, AMX, ARNA, FB, NCT$, NCT, NRZ$, NWSA, MSFT, DTV", "Weekly Preview: Focus Shifts from Earnings to Economy", "Best Stocks: Biotech Still Holding Top Spots", "Pre-Market Most Active for May 8, 2013 : BIP, BAC, CIE, BBRY, VCLK, VNTV, TLK, CFX, SODA, ARNA, SIRI, FB", "Patients Dosed in Arena Study - Analyst Blog", "WEEKLY CFO SELLS HIGHLIGHT: ZNGA, ARNA, JACK, TUMI, PANW", "ARNA/Eisai's Belviq Filed in Mexico - Analyst Blog", "Vivus Opts for Royalty Financing - Analyst Blog", "Loss at OREX Narrower than Expected - Analyst Blog", "Arena Cuts Loss, Misses Estimates - Analyst Blog", "Company News for March 05, 2013 - Corporate Summary", "Expanded Access for VIVUS' Qsymia - Analyst Blog", "Vivus Reports Wider Loss - Analyst Blog", "CHMP Still Negative on Vivus' Qsiva - Analyst Blog", "Discovery Laboratories: Innovative Financing Is A Catalyst To Buy The Stock", "Vivus Unveils Qsymia Study Results - Analyst Blog", "Arena Falters on Belviq EU Approval - Analyst Blog", "Pre-Market Most Active for Jan 22, 2013 : SNV, VOD, RIMM, BAC, SNY, BCS, VZ, ARNA, FB, NOK, AAPL, DELL", "Update on Orexigen's Contrave - Analyst Blog", "Pre-Market Earnings Report for March 4, 2013 : RIG, SSYS, TECD, ARNA, CEL, BYD, YGE, ALVR", "Takeda Terminates Amylin Agreement - Analyst Blog", "Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)", "3 Bio-Pharmas Trades Offering Good Upside Potential", "Arena Cuts Loss, Affirms Sales View - Analyst Blog", "Vivus Misses 3Q Estimates - Analyst Blog", "Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)", "CHMP Negative on Vivus' Qsiva - Analyst Blog", "Best of 2012: Small Caps", "Arena Pharma Initiates PAH Study - Analyst Blog", "Vivus Expects European Setback - Analyst Blog", "The right data is key to spotting trends", "Pre-Market Most Active for Sep 21, 2012 : BAC, ORCL, FB, VVUS, QQQ, SIRI, NOK, BCS, S, ARNA, KBH, AI", "Vivus Launches Obesity Drug Qsymia - Analyst Blog", "Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS", "After Hours Most Active for Aug 31, 2012 : QQQ, MO, ARR, MRK, BAC, CTL, EXEL, NIHD, ESV, INTC, SIRI, ARNA", "Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)", "Arena Pharma Initiates PAH Study - Analyst Blog", "Arena Cuts Loss, Sales Climb - Analyst Blog", "Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape", "Arena Pharmaceuticals, Inc.Enters Oversold Territory - Tale of the Tape", "Pre-Market Most Active for Jul 18, 2012 : BAC, VVUS, SAN, AGNC, ARNA, BHP, TOT, OREX, ERIC, QQQ, RIO, SBH", "Glory for Vivus After Arena - Analyst Blog", "Pre-Market Most Active for Aug 29, 2012 : SAN, NOK, ERIC, BAC, MCP, TI/A, JOY, QQQ, ARNA, TFM, WMGI, EBAY", "Arena Seeks Approval in Switzerland - Analyst Blog", "Pre-Market Most Active for Jul 13, 2012 : JPM, BAC, TWO, QQQ, WFC, BP, TOT, INFY, VVUS, ARNA, FB, GMCR", "Pre-Market Most Active for Jul 11, 2012 : BZH, UN, QQQ, BAC, BUD, ARNA, CYS, PSEC, UBS, OREX, ERIC, SIRI", "Pre-Market Most Active for Jul 9, 2012 : SIRI, AGP, QQQ, BAC, STO, WLP, ARNA, WCG, TSM, SPIL, FB, TWTC", "Pre-Market Most Active for Jul 6, 2012 : BAC, SAP, ARNA, QQQ, INFA, FB, AAPL, STX", "Pre-Market Most Active for Jul 3, 2012 : BCS, UN, SNY, AZN, MODL, BAC, NOK, NSPH, ARNA, QQQ, MSFT, AAPL", "Second Time Lucky for Arena's Belviq - Analyst Blog", "Pre-Market Most Active for Jul 16, 2012 : HGSI, C, BAC, PRX, TOT, QQQ, NTT, SIRI, FTE, OREX, ARNA, ASML", "Arena Seeks Approval in Switzerland - Analyst Blog", "Pre-Market Most Active for Jun 27, 2012 : ERIC, AMRN, BAC, FB, ABB, JNJ, TKC, NOK, OMER, ARNA, NVO, ZNGA", "After Hours Most Active for Jun 27, 2012 : QQQ, SLE, BAC, EXTR, QNST, CENTA, GXP, ARNA, WM, VSH, VRSN, AET", "Pre-Market Most Active for Jun 26, 2012 : NOK, BAC, PC, TKC, SDRL, ASML, ARNA, STX, NJ, NWSA, ZNGA, VOD", "Pre-Market Most Active for Jun 25, 2012 : TI/A, ARNA, QSFT, FB, QQQ, ASML, RIMM", "Pre-Market Most Active for Jun 22, 2012 : BAC, ARNA, CS, ASML, RDS/A, MS, SDRL, FB, ABB, ZNGA, QQQ, TSLA", "Pre-Market Most Active for Jun 21, 2012 : SUNH, ONXX, CELG, BAC, ARNA, JNJ, VOD, ASX, BHP, ING, BP, GNMK", "Pre-Market Most Active for Jun 29, 2012 : ELT, BAC, NOK, F, RIMM, QQQ, BCS, BP, VOD, ARMH, AAPL, ARNA", "Pre-Market Most Active for Jun 28, 2012 : BAC, BCS, JPM, ARNA, VRTX, NOK, OREX, C, ETP, EBAY, FB, QQQ", "Pre-Market Most Active for Jun 18, 2012 : BAC, BHP, GSK, CS, NOK, CAJ, ARNA, QQQ, FB, ZNGA, SPIL, MSFT", "Pre-Market Most Active for Jun 15, 2012 : BAC, NOK, ARNA, MT, ARMH, BP, QQQ, ZNGA, FB, BCS, C, AAPL", "After Hours Most Active for Jun 15, 2012 : BAC, FB, KGC, IO, INTC, QQQ, NWSA, ABX, SPF, GG, DELL, ARNA", "Pre-Market Most Active for Jun 14, 2012 : NOK, BAC, QSFT, DDD, IVN, RDS/A, UN, QQQ, DNDN, ARNA, VOD, ZNGA", "Pre-Market Most Active for Jun 13, 2012 : JNJ, BAC, TFM, ARNA, MT, C^J/CL, QQQ, ZNGA, ABB, FSLR, ASML, STO", "Pre-Market Most Active for Jun 12, 2012 : BAC, TI/A, KORS, KT, PC, NOK, QQQ, ARMH, ARNA, AAPL, MSFT, ZNGA", "Pre-Market Most Active for Jun 20, 2012 : BAC, VOD, NOK, BHP, BONA, ING, GSK, ARNA, PG, QSFT, ADBE, IDIX", "Pre-Market Most Active for Jun 19, 2012 : BAC, WAG, ORCL, E, NOK, ERIC, ASML, ARNA, QQQ, WES, AAPL, JCP", "Pre-Market Most Active for Jun 18, 2012 : BAC, BHP, GSK, CS, NOK, CAJ, ARNA, QQQ, FB, ZNGA, SPIL, MSFT", "The Strongest Small-Caps in the Market", "Pre-Market Most Active for May 17, 2012 : SNY, BAC, BUD, MT, MTL, WMT, QQQ, VOD, AAPL, DNDN, ZNGA, ARNA", "Pre-Market Most Active for May 16, 2012 : CTL, SNY, BAC, GE, NCT, MT, QQQ, ARNA, SINA, PETD, ZNGA, RIMM", "After Hours Most Active for May 15, 2012 : DFG, TPX, JCP, GSM, QQQ, BAC, ARNA, CCJ, AIG, VELT, INTC, NWSA", "Pre-Market Most Active for May 14, 2012 : BAC, CHK, NOK, BBVA, CS, SIRI, JPM, ARNA, QQQ, YHOO, AAPL, FRAN", "Pre-Market Most Active for Jun 11, 2012 : BAC, DUK, PGN, NOK, QQQ, C, STD, AAPL, FB, VOD, ARNA, ZNGA", "Pre-Market Most Active for May 8, 2012 : BAC, SIRI, TEF, ARNA, AIG, FOSL, BCS, IHG, QQQ, FTE, GTXI, MAKO", "Largest option buying in equities so far", "Arena Pharma Drug under EU Review - Analyst Blog", "Company News for March 27, 2012 - Corporate Summary", "How Qnexa's Positive Panel Review Generated Alpha For Short Sellers", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Pre-Market Most Active for May 11, 2012 : JPM, ARNA, NVDA, QQQ, SIRI, WWWW, AAPL", "Zacks #1 Rank Additions for Tuesday - Tale of the Tape", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Arena Pharma Files Response to CRL - Analyst Blog", "Stocks Mixed as Commodities Slip; GDP Data Raises Concern Over Economy", "Mid-Day Update: Stocks Mixed at Session's Half; GDP, Employment Data Weigh", "Opening View: DJIA, SPX Set to Extend Upward Momentum; MSFT, THC, ATVI on the Radar", "What large call buyer sees in Arena", "Zacks #1 Rank Additions for Monday - Tale of the Tape", "Options Trade of the Day: An Orexigen Therapeutics Bull Call Spread", "Stocks Higher in Mid-Day Trading as Investors Eye Housing Data, G-20, Earnings", "Mid-Day Update: Stocks Solidly Higher as New Housing Data Adds to Positive Sentiment", "Looking for Value in September's Biggest Losers", "What Analysts Won't Tell You About Arena", "Bullish Arena (ARNA) trade boosts options volume", "The Best Performing Small-Cap Stocks of July 2010 -- Where Are They Headed Next?", "3 Stocks to Watch: Arena Pharmaceuticals, Boeing, and InterMune", "Tuesday Winners: Vivus, Ivanhoe Mines and Brooks Automation", "Monday Losers: Acxiom, Aon Corp and VIVUS", "Arena Pharmaceuticals rises after weight-loss drug deal with Eisai", "Friday Winners: Thor Industries, Arena Pharma and Allergan", "Thursday Winners: Arena Pharma, Christopher & Banks and BJ's Wholesale", "Monday Winners: Amylin, Orexigen and PolyMet Minerals", "Thursday Winners: Arena Pharma, Clean Energy and West Marine"], "Elapsed Time": ["12 HOURS AGO", "JUN 2, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 18, 2020", "12 HOURS AGO", "MAY 13, 2020", "MAY 8, 2020", "MAY 8, 2020", "MAY 7, 2020", "MAY 7, 2020", "APR 27, 2020", "APR 19, 2020", "MAY 18, 2020", "APR 19, 2020", "APR 17, 2020", "APR 13, 2020", "APR 9, 2020", "MAR 15, 2020", "MAR 13, 2020", "FEB 28, 2020", "APR 19, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 16, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 7, 2020", "JAN 28, 2020", "FEB 27, 2020", "JAN 16, 2020", "DEC 23, 2019", "DEC 15, 2019", "NOV 11, 2019", "NOV 8, 2019", "NOV 8, 2019", "NOV 8, 2019", "JAN 19, 2020", "OCT 16, 2019", "OCT 11, 2019", "OCT 3, 2019", "OCT 2, 2019", "SEP 30, 2019", "SEP 20, 2019", "SEP 11, 2019", "NOV 7, 2019", "AUG 12, 2019", "AUG 8, 2019", "AUG 8, 2019", "AUG 7, 2019", "AUG 7, 2019", "AUG 2, 2019", "AUG 1, 2019", "SEP 4, 2019", "JUN 6, 2019", "MAY 10, 2019", "MAY 8, 2019", "APR 10, 2019", "FEB 28, 2019", "FEB 27, 2019", "FEB 26, 2019", "JUL 3, 2019", "JAN 10, 2019", "DEC 13, 2018", "DEC 7, 2018", "DEC 6, 2018", "NOV 21, 2018", "NOV 17, 2018", "NOV 16, 2018", "FEB 25, 2019", "NOV 16, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 16, 2018", "NOV 15, 2018", "NOV 9, 2018", "OCT 30, 2018", "SEP 25, 2018", "SEP 5, 2018", "AUG 31, 2018", "AUG 30, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 9, 2018", "JUL 27, 2018", "JUN 21, 2018", "JUN 7, 2018", "JUN 4, 2018", "MAY 9, 2018", "AUG 15, 2018", "MAY 1, 2018", "APR 21, 2018", "APR 13, 2018", "MAR 26, 2018", "MAR 24, 2018", "MAR 23, 2018", "MAR 22, 2018", "MAY 7, 2018", "MAY 1, 2018", "APR 21, 2018", "MAR 21, 2018", "MAR 21, 2018", "MAR 21, 2018", "MAR 20, 2018", "MAR 20, 2018", "MAR 22, 2018", "MAR 20, 2018", "MAR 20, 2018", "MAR 20, 2018", "MAR 20, 2018", "MAR 20, 2018", "MAR 15, 2018", "MAR 15, 2018", "MAR 20, 2018", "MAR 15, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 6, 2018", "MAR 15, 2018", "FEB 26, 2018", "FEB 23, 2018", "FEB 14, 2018", "FEB 3, 2018", "JAN 22, 2018", "JAN 18, 2018", "JAN 15, 2018", "FEB 28, 2018", "DEC 11, 2017", "NOV 13, 2017", "NOV 8, 2017", "NOV 7, 2017", "OCT 30, 2017", "OCT 15, 2017", "OCT 9, 2017", "JAN 4, 2018", "SEP 26, 2017", "SEP 12, 2017", "SEP 7, 2017", "SEP 7, 2017", "AUG 9, 2017", "AUG 8, 2017", "AUG 4, 2017", "SEP 28, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 4, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 2, 2017", "AUG 1, 2017", "AUG 1, 2017", "AUG 1, 2017", "AUG 2, 2017", "AUG 1, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 17, 2017", "AUG 1, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUL 12, 2017", "JUL 12, 2017", "JUL 17, 2017", "JUL 14, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 12, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 11, 2017", "JUL 5, 2017", "JUL 3, 2017", "JUN 30, 2017", "JUN 23, 2017", "JUN 23, 2017", "JUL 7, 2017", "JUN 22, 2017", "JUN 22, 2017", "JUN 20, 2017", "JUN 19, 2017", "JUN 14, 2017", "MAY 24, 2017", "JUN 23, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 10, 2017", "MAY 4, 2017", "APR 19, 2017", "APR 19, 2017", "MAY 23, 2017", "APR 18, 2017", "APR 18, 2017", "APR 18, 2017", "APR 10, 2017", "APR 6, 2017", "MAR 15, 2017", "MAR 15, 2017", "APR 18, 2017", "MAR 15, 2017", "MAR 14, 2017", "FEB 27, 2017", "JAN 13, 2017", "JAN 11, 2017", "JAN 9, 2017", "JAN 9, 2017", "MAR 15, 2017", "JAN 6, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 6, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 3, 2017", "JAN 3, 2017", "JAN 3, 2017", "DEC 18, 2016", "NOV 8, 2016", "JAN 4, 2017", "OCT 11, 2016", "SEP 2, 2016", "AUG 17, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 1, 2016", "JUL 20, 2016", "NOV 8, 2016", "JUL 14, 2016", "JUL 14, 2016", "JUL 1, 2016", "JUL 1, 2016", "JUL 1, 2016", "JUN 9, 2016", "JUN 1, 2016", "JUL 19, 2016", "JUL 14, 2016", "JUL 14, 2016", "JUL 1, 2016", "MAY 6, 2016", "MAY 4, 2016", "APR 21, 2016", "APR 13, 2016", "JUN 1, 2016", "APR 12, 2016", "APR 12, 2016", "APR 12, 2016", "APR 8, 2016", "APR 7, 2016", "MAR 11, 2016", "MAR 8, 2016", "APR 13, 2016", "MAR 1, 2016", "FEB 26, 2016", "FEB 9, 2016", "JAN 13, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 7, 2016", "MAR 4, 2016", "MAR 1, 2016", "JAN 5, 2016", "JAN 5, 2016", "JAN 4, 2016", "DEC 30, 2015", "DEC 30, 2015", "JAN 7, 2016", "DEC 29, 2015", "DEC 23, 2015", "DEC 22, 2015", "DEC 18, 2015", "DEC 14, 2015", "DEC 14, 2015", "DEC 8, 2015", "DEC 29, 2015", "DEC 7, 2015", "DEC 4, 2015", "DEC 4, 2015", "DEC 3, 2015", "DEC 3, 2015", "DEC 2, 2015", "DEC 1, 2015", "DEC 7, 2015", "DEC 1, 2015", "NOV 30, 2015", "NOV 30, 2015", "NOV 23, 2015", "NOV 12, 2015", "NOV 11, 2015", "NOV 10, 2015", "DEC 1, 2015", "NOV 6, 2015", "NOV 2, 2015", "OCT 30, 2015", "OCT 30, 2015", "OCT 17, 2015", "OCT 16, 2015", "SEP 18, 2015", "NOV 10, 2015", "SEP 10, 2015", "SEP 5, 2015", "AUG 28, 2015", "AUG 24, 2015", "AUG 23, 2015", "AUG 23, 2015", "AUG 12, 2015", "SEP 18, 2015", "AUG 6, 2015", "AUG 4, 2015", "AUG 4, 2015", "JUL 21, 2015", "JUL 15, 2015", "JUL 5, 2015", "JUN 13, 2015", "AUG 6, 2015", "MAY 16, 2015", "MAY 16, 2015", "MAY 13, 2015", "MAY 12, 2015", "MAY 12, 2015", "MAY 11, 2015", "MAY 7, 2015", "JUN 9, 2015", "APR 24, 2015", "APR 23, 2015", "APR 21, 2015", "APR 21, 2015", "APR 15, 2015", "APR 13, 2015", "APR 12, 2015", "APR 29, 2015", "APR 8, 2015", "APR 8, 2015", "MAR 24, 2015", "MAR 22, 2015", "MAR 19, 2015", "MAR 14, 2015", "MAR 12, 2015", "APR 10, 2015", "MAR 9, 2015", "MAR 8, 2015", "MAR 3, 2015", "MAR 3, 2015", "MAR 3, 2015", "MAR 2, 2015", "MAR 2, 2015", "MAR 11, 2015", "FEB 26, 2015", "FEB 18, 2015", "FEB 10, 2015", "FEB 9, 2015", "FEB 6, 2015", "FEB 2, 2015", "JAN 25, 2015", "FEB 27, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 17, 2015", "JAN 16, 2015", "JAN 15, 2015", "JAN 22, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 8, 2015", "JAN 8, 2015", "JAN 8, 2015", "JAN 8, 2015", "JAN 12, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 6, 2015", "DEC 27, 2014", "DEC 27, 2014", "JAN 7, 2015", "DEC 24, 2014", "DEC 21, 2014", "DEC 7, 2014", "DEC 3, 2014", "DEC 3, 2014", "NOV 17, 2014", "NOV 13, 2014", "DEC 24, 2014", "NOV 10, 2014", "NOV 4, 2014", "OCT 31, 2014", "OCT 22, 2014", "OCT 8, 2014", "OCT 7, 2014", "OCT 6, 2014", "NOV 11, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 19, 2014", "SEP 18, 2014", "SEP 17, 2014", "SEP 13, 2014", "SEP 12, 2014", "OCT 4, 2014", "SEP 9, 2014", "SEP 3, 2014", "AUG 30, 2014", "AUG 24, 2014", "AUG 4, 2014", "JUL 31, 2014", "JUL 21, 2014", "SEP 11, 2014", "JUL 16, 2014", "JUL 11, 2014", "JUL 8, 2014", "JUL 8, 2014", "JUL 7, 2014", "JUL 7, 2014", "JUN 11, 2014", "JUL 21, 2014", "MAY 22, 2014", "MAY 21, 2014", "MAY 21, 2014", "MAY 20, 2014", "MAY 15, 2014", "MAY 12, 2014", "MAY 12, 2014", "JUN 5, 2014", "APR 10, 2014", "APR 10, 2014", "APR 3, 2014", "MAR 17, 2014", "MAR 5, 2014", "MAR 3, 2014", "APR 24, 2014", "FEB 27, 2014", "FEB 14, 2014", "FEB 10, 2014", "FEB 10, 2014", "JAN 16, 2014", "JAN 8, 2014", "DEC 19, 2013", "FEB 28, 2014", "NOV 12, 2013", "NOV 8, 2013", "NOV 8, 2013", "NOV 7, 2013", "NOV 1, 2013", "OCT 18, 2013", "OCT 16, 2013", "DEC 17, 2013", "OCT 10, 2013", "OCT 8, 2013", "OCT 7, 2013", "SEP 30, 2013", "SEP 26, 2013", "SEP 25, 2013", "SEP 18, 2013", "OCT 15, 2013", "SEP 11, 2013", "SEP 9, 2013", "AUG 30, 2013", "AUG 7, 2013", "AUG 5, 2013", "AUG 1, 2013", "JUL 29, 2013", "SEP 12, 2013", "JUL 3, 2013", "JUN 28, 2013", "JUN 19, 2013", "JUN 19, 2013", "JUN 12, 2013", "MAY 28, 2013", "MAY 9, 2013", "JUL 23, 2013", "MAY 6, 2013", "MAY 3, 2013", "MAY 3, 2013", "MAY 3, 2013", "MAY 2, 2013", "APR 26, 2013", "APR 22, 2013", "MAY 8, 2013", "APR 9, 2013", "APR 7, 2013", "APR 3, 2013", "APR 2, 2013", "MAR 14, 2013", "MAR 8, 2013", "MAR 5, 2013", "APR 18, 2013", "FEB 26, 2013", "FEB 22, 2013", "FEB 14, 2013", "FEB 7, 2013", "JAN 23, 2013", "JAN 22, 2013", "JAN 10, 2013", "MAR 1, 2013", "DEC 31, 2012", "DEC 12, 2012", "NOV 21, 2012", "NOV 9, 2012", "NOV 8, 2012", "OCT 25, 2012", "OCT 22, 2012", "JAN 4, 2013", "OCT 15, 2012", "SEP 25, 2012", "SEP 21, 2012", "SEP 21, 2012", "SEP 20, 2012", "AUG 31, 2012", "AUG 31, 2012", "OCT 15, 2012", "OCT 15, 2012", "AUG 14, 2012", "AUG 1, 2012", "JUL 20, 2012", "JUL 18, 2012", "JUL 18, 2012", "AUG 29, 2012", "JUL 13, 2012", "JUL 13, 2012", "JUL 11, 2012", "JUL 9, 2012", "JUL 6, 2012", "JUL 3, 2012", "JUN 29, 2012", "JUL 16, 2012", "JUL 13, 2012", "JUN 27, 2012", "JUN 27, 2012", "JUN 26, 2012", "JUN 25, 2012", "JUN 22, 2012", "JUN 21, 2012", "JUN 29, 2012", "JUN 28, 2012", "JUN 18, 2012", "JUN 15, 2012", "JUN 15, 2012", "JUN 14, 2012", "JUN 13, 2012", "JUN 12, 2012", "JUN 20, 2012", "JUN 19, 2012", "JUN 18, 2012", "MAY 21, 2012", "MAY 17, 2012", "MAY 16, 2012", "MAY 15, 2012", "MAY 14, 2012", "JUN 11, 2012", "MAY 8, 2012", "MAY 7, 2012", "MAR 27, 2012", "MAR 27, 2012", "FEB 23, 2012", "JAN 26, 2012", "MAY 11, 2012", "JAN 17, 2012", "JAN 11, 2012", "JAN 6, 2012", "MAY 26, 2011", "MAY 26, 2011", "MAY 10, 2011", "JAN 25, 2011", "JAN 23, 2012", "NOV 22, 2010", "OCT 25, 2010", "OCT 25, 2010", "OCT 4, 2010", "SEP 7, 2010", "AUG 3, 2010", "JUL 28, 2010", "DEC 21, 2010", "JUL 13, 2010", "JUL 12, 2010", "JUL 5, 2010", "JUL 2, 2010", "JUL 1, 2010", "JUN 28, 2010", "JUL 15, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/3-pot-stocks-worth-a-second-look-2020-06-26", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-jumped-higher-today-2020-06-02", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-plce-veev-arna-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-arca-biopharma-aerpio-pharma-triumph-group-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-blue-hat-arca-biopharma-aerpio-pharma-2020-05-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-28-2020%3A-phas-arna-iova-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-aerpio-pharma-arena-pharma-triumph-group-2020-05-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-18-2020%3A-jnjvirarnablue-2020-05-18", "https://www.nasdaq.com/articles/3-pot-stocks-worth-a-second-look-2020-06-26", "https://www.nasdaq.com/articles/arena-pharmaceuticals-breaks-below-200-day-moving-average-notable-for-arna-2020-05-13", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q1-2020-earnings-call-transcript-2020-05-08", "https://www.nasdaq.com/articles/look-under-the-hood%3A-vbk-has-12-upside-2020-05-08", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-arena-pharmaceutical-inc.-q1-earnings-report-2020-05-07", "https://www.nasdaq.com/articles/arena-pharmaceutical-q1-20-earnings-conference-call-at-4%3A30-pm-et-2020-05-07", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-for-june-5th-2020-04-27", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-18-2020%3A-virarnablue-2020-05-18", "https://www.nasdaq.com/articles/3-reasons-medical-marijuana-is-a-better-long-term-investment-than-recreational-pot-2020-04", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-shares-cross-above-200-dma-2020-04-17", "https://www.nasdaq.com/articles/arna-august-21st-options-begin-trading-2020-04-13", "https://www.nasdaq.com/articles/arna-may-29th-options-begin-trading-2020-04-09", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-for-may-1st-2020-03-13", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2-28-2020-2020-02-28", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-arena-pharmaceutical-inc.-q4-earnings-report-2020-02-26", "https://www.nasdaq.com/articles/arena-pharmaceutical-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-02-26", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-benjamin-graham-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/fda-asks-that-weight-loss-drug-belviq-be-pulled-from-the-market-2020-02-13", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2-13-2020-2020-02-13", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-arna-2020-02-07", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-for-jkl-2020-01-28", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q4-2019-earnings-call-transcript-2020-02-27", "https://www.nasdaq.com/articles/arena-pharma-to-present-at-j.p.-morgan-conference-webcast-at-1%3A00-pm-et-2020-01-16", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-arna-mygn-icpt-2019-12-23", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-benjamin-graham-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q3-2019-earnings-call-transcript-2019-11-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-08-2019%3A-arwriovagharna-2019-11-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-08-2019%3A-iovagharna-2019-11-08", "https://www.nasdaq.com/articles/only-1-number-mattered-in-arena-pharmaceuticals-q3-results-and-it-was-big-2019-11-08", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-benjamin-graham-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-rtn-arna-team-2019-10-16", "https://www.nasdaq.com/articles/arna-november-29th-options-begin-trading-2019-10-11", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-for-november-22nd-2019-10-03", "https://www.nasdaq.com/articles/arena-pharma-to-present-at-cantor-global-conference-webcast-at-3%3A00-pm-et-2019-10-02", "https://www.nasdaq.com/articles/arena-pharmaceuticals-is-now-oversold-arna-2019-09-30", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-mrk-abt-arna-2019-09-20", "https://www.nasdaq.com/articles/first-week-of-arna-april-2020-options-trading-2019-09-11", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-arena-pharmaceutical-inc.-q3-earnings-report-2019-11-07", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-for-september-27th-2019-08-12", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-arna-twlo-avlr-2019-08-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-arena-pharmaceutical-inc.-q2-earnings-report-2019-08-07", "https://www.nasdaq.com/articles/arena-pharmaceutical-q2-19-earnings-conference-call-at-4%3A30-pm-et-2019-08-07", "https://www.nasdaq.com/articles/strange%3A-bullish-arna-analysts-actually-see-3.78-downside-2019-08-02", "https://www.nasdaq.com/articles/first-week-of-arna-september-20th-options-trading-2019-08-01", "https://www.nasdaq.com/articles/arena-pharmaceutical-to-present-at-wells-fargo-conference-webcast-at-8%3A30-am-2019-09-04", "https://www.nasdaq.com/articles/heres-why-united-therapeutics-fell-18.1-may-2019-06-06", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q1-2019-earnings-call-transcript-2019-05-10", "https://www.nasdaq.com/articles/earnings-summary%3A-details-arena-pharmaceutical-inc.-q1-earnings-report-2019-05-08", "https://www.nasdaq.com/articles/arena-pharmaceutical-needham-healthcare-conference-12%3A00-pm-et-2019-04-10", "https://www.nasdaq.com/articles/united-therapeutics-uthr-q4-earnings-sales-beat-estimates-2019-02-28", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-beats-on-q4-earnings-revenues-2019-02-27", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-arna-q4-2018-earnings-conference-call-transcript-2019-02-26", "https://www.nasdaq.com/articles/arna-crosses-above-average-analyst-target-2019-07-03", "https://www.nasdaq.com/articles/arena-pharma-participate-jp-morgan-healthcare-conference-1230-pm-et-2019-01-10", "https://www.nasdaq.com/articles/arna-february-2019-options-begin-trading-2018-12-13", "https://www.nasdaq.com/articles/why-is-arena-pharmaceuticals-arna-up-8.1-since-last-earnings-report-2018-12-07", "https://www.nasdaq.com/articles/arna-crosses-below-key-moving-average-level-2018-12-06", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-drug-wins-nod-in-china-arena-up-on-licensing-deal-2018-11-21", "https://www.nasdaq.com/articles/my-top-3-favorite-clinical-stage-biotech-stocks-buy-2018-11-17", "https://www.nasdaq.com/articles/arena-arna-out-licenses-rights-to-pah-drug-stock-up-22-2018-11-16", "https://www.nasdaq.com/articles/5-clinical-stage-biotech-stocks-to-buy-2019-02-25", "https://www.nasdaq.com/articles/health-care-sector-update-11162018-arnauthrsgenhcm-2018-11-16", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-stock-soaring-today-2018-11-15", "https://www.nasdaq.com/articles/thursdays-etf-movers-xbi-itb-2018-11-15", "https://www.nasdaq.com/articles/mid-day-market-update-smart-final-stores-rises-following-strong-q3-earnings-remark", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-jumped-much-306-today-2018-11-15", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-walmart-profit-tops-expectations-2018-11-15", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-smart-final-stores-and-tilray-jumped-today-2018-11-15", "https://www.nasdaq.com/articles/health-care-sector-update-11162018-amedarna-sgenhcm-2018-11-16", "https://www.nasdaq.com/articles/health-care-sector-update-11152018-arnauthrqureabio-2018-11-15", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-beats-on-q3-earnings-and-sales-2018-11-09", "https://www.nasdaq.com/articles/analysts-estimate-arena-pharmaceuticals-arna-to-report-a-decline-in-earnings%3A-what-to-0", "https://www.nasdaq.com/articles/arena-arna-posts-favorable-top-line-data-on-pain-candidate-2018-09-25", "https://www.nasdaq.com/articles/why-is-arena-pharmaceuticals-arna-up-7.4-since-last-earnings-report-2018-09-05", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-shares-cross-above-200-dma-2018-08-31", "https://www.nasdaq.com/articles/7-stocks-set-for-monster-growth-in-2018-2018-08-30", "https://www.nasdaq.com/articles/health-care-sector-update-11152018-arna-uthr-qure-abio-2018-11-15", "https://www.nasdaq.com/articles/health-care-sector-update-11152018-arnauthrqureabio-2018-11-15", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-beats-on-q3-earnings-and-sales-2018-11-09", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2018-07-27", "https://www.nasdaq.com/articles/notable-thursday-option-activity-gs-arna-lfgr-2018-06-21", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-up-15.1-since-earnings-report%3A-can-it-continue-2018-06-07", "https://www.nasdaq.com/articles/7-stocks-set-for-monster-growth-in-2018-2018-06-04", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q1-loss-wider-than-expected-2018-05-09", "https://www.nasdaq.com/articles/arena-pharmaceuticals-becomes-oversold-arna-2018-08-15", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2018-05-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-04-21", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-up-7-since-earnings-report%3A-can-it-continue-2018-04-13", "https://www.nasdaq.com/articles/obesity-drugmaker-just-made-comeback-while-another-declared-bankruptcy-2018-03-26", "https://www.nasdaq.com/articles/3-biotech-stocks-skyrocketed-week-are-they-buys-2018-03-24", "https://www.nasdaq.com/articles/arena-pharmaceuticals-takes-aim-celgene-2018-03-23", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-in-focus%3A-stock-moves-10.7-higher-2018-03-22", "https://www.nasdaq.com/articles/drug-biotech-q1-earnings-lineup-on-may-8%3A-jazz-arna-more-2018-05-07", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2018-05-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-arna-up-on-study-data-prta-teams-up-with-celgene-2018-03-21", "https://www.nasdaq.com/articles/company-news-for-mar-21-2018-2018-03-21", "https://www.nasdaq.com/articles/why-whiting-petroleum-arena-pharmaceuticals-and-first-majestic-silver-jumped-today-2018-03", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-inc-surged-again-wednesday-2018-03-21", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-25-arena-pharmaceuticals-shares-spike-higher-2018-03-20", "https://www.nasdaq.com/articles/arenas-arna-etrasimod-meets-phase-ii-colitis-study-goal-2018-03-20", "https://www.nasdaq.com/articles/pre-market-most-active-mar-22-2018-tvix-qqq-fb-mu-nok-arna-bac-baba-sqqq-db-mfgp-sbgl-2018", "https://www.nasdaq.com/articles/pre-market-most-active-mar-20-2018-fb-tvix-qqq-eep-mu-orcl-arna-ns-bpl-mfgp-sbgl-eric-2018", "https://www.nasdaq.com/articles/arena-pharmaceuticals-takes-big-step-forward-2018-03-20", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2018-03-20", "https://www.nasdaq.com/articles/mid-afternoon-market-update-mulesoft-gains-following-report-takeover-interest-salesforce", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-shares-are-rocketing-316-higher-today-2018-03-20", "https://www.nasdaq.com/articles/arena-pharmaceuticals-becomes-oversold-arna-2018-03-15", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q4-earnings-beat-sales-down-y-y-2018-03-15", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-gain-oracle-shares-fall-following-q3-results-2018-03-20", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q4-2017-earnings-conference-call-transcript-2018-03-15", "https://www.nasdaq.com/articles/arena-arna-posts-narrower-than-expected-q4-loss-shares-up-2018-03-14", "https://www.nasdaq.com/articles/orexigen-plummets-on-filing-of-chapter-11-of-bankruptcy-code-2018-03-14", "https://www.nasdaq.com/articles/health-care-sector-update-03142018-kool-arna-qure-vygr-brkr-2018-03-14", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-yelp-arna-ndaq-2018-03-14", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-14-2018-tsg-sig-arna-vygr-srlp-expr-vra-clsd-tgls-cui", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2018-03-06", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-arena-pharmaceuticals-arna-stock-2018-03-15", "https://www.nasdaq.com/articles/commit-buy-arena-pharmaceuticals-30-earn-195-annualized-using-options-2018-02-26", "https://www.nasdaq.com/articles/7-stocks-set-for-monster-growth-in-2018-2018-02-23", "https://www.nasdaq.com/articles/celgenes-future-growth-could-depend-competitors-trial-quarter-2018-02-14", "https://www.nasdaq.com/articles/3-top-obesity-drug-stocks-consider-buying-now-2018-02-03", "https://www.nasdaq.com/articles/7-stocks-set-for-monster-growth-in-2018-2018-01-22", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-pbe-2018-01-18", "https://www.nasdaq.com/articles/three-interviews-jp-morgan-healthcare-conference-2018-01-15", "https://www.nasdaq.com/articles/we-did-math-dwaq-can-go-119-2018-02-28", "https://www.nasdaq.com/articles/heres-what-pushed-arena-pharmaceuticals-inc-106-november-2017-12-11", "https://www.nasdaq.com/articles/arena-arna-completes-enrolment-in-etrasimod-phase-ii-study-2017-11-13", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q3-loss-widens-y-y-sales-beat-2017-11-08", "https://www.nasdaq.com/articles/single-event-rocketed-arena-pharmaceuticals-inc-higher-10-october-2017-11-07", "https://www.nasdaq.com/articles/whats-in-the-cards-for-arena-arna-this-earnings-season-2017-10-30", "https://www.nasdaq.com/articles/do-1-thing-and-lower-your-risk-13-types-cancer-2017-10-15", "https://www.nasdaq.com/articles/heres-what-lifted-arena-pharmaceuticals-inc-stock-september-2017-10-09", "https://www.nasdaq.com/articles/orexigen-struggles-as-contrave-commercialization-costs-rise-2018-01-04", "https://www.nasdaq.com/articles/biotech-craters-70-late-stage-alzheimers-drug-failure-2017-09-26", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-stock-dives-on-drug-warning-2017-09-12", "https://www.nasdaq.com/articles/jj-jnj-pah-drugs-u.s.-label-expanded-for-pediatric-use-2017-09-07", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-down-1.5-since-earnings-report%3A-can-it-rebound-2017-09-07", "https://www.nasdaq.com/articles/1-very-clear-reason-arena-pharmaceuticals-inc-skyrocketed-41-july-2017-08-09", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q2-loss-wider-than-expected-2017-08-08", "https://www.nasdaq.com/articles/will-expenses-hit-envision-healthcare-evhc-q2-earnings-2017-08-04", "https://www.nasdaq.com/articles/orexigens-orex-contrave-sales-improving-on-promotions-2017-09-28", "https://www.nasdaq.com/articles/sucampo-scmp-q2-earnings-revenues-beat-estimates-up-y-y-2017-08-03", "https://www.nasdaq.com/articles/biomarin-bmrn-q2-loss-narrows-sales-surpass-estimates-2017-08-03", "https://www.nasdaq.com/articles/can-myriad-genetics-mygn-spring-a-surprise-in-q4-earnings-2017-08-03", "https://www.nasdaq.com/articles/can-jazz-pharma-jazz-spring-a-surprise-in-q2-earnings-2017-08-03", "https://www.nasdaq.com/articles/inovio-ino-q2-earnings%3A-what-lies-ahead-for-the-stock-2017-08-02", "https://www.nasdaq.com/articles/whats-in-store-for-puma-pbyi-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-kite-pharma-kite-in-q2-earnings-2017-08-04", "https://www.nasdaq.com/articles/mylan-myl-to-report-q2-earnings%3A-whats-in-the-cards-2017-08-02", "https://www.nasdaq.com/articles/can-cvs-health-cvs-pull-a-surprise-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-celldex-cldx-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/will-acadia-acad-pull-off-a-surprise-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/gw-pharmaceuticals-gwph-q3-earnings%3A-what-lies-in-store-2017-08-01", "https://www.nasdaq.com/articles/can-mallinckrodt-mnk-deliver-a-beat-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/whats-in-the-cards-for-adverum-advm-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/whats-in-store-for-arena-arna-this-earnings-season-2017-08-02", "https://www.nasdaq.com/articles/can-ligand-lgnd-pull-a-surprise-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/whats-in-the-cards-for-merrimack-mack-in-q2-earnings-2017-07-28", "https://www.nasdaq.com/articles/astrazeneca-azn-beats-on-q2-earnings-falls-on-failed-study-2017-07-28", "https://www.nasdaq.com/articles/these-3-stocks-have-jumped-60-single-month-2017-07-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-geron-gern-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-july-24th-2017-07-24", "https://www.nasdaq.com/articles/quintiles-ims-novel-way-invest-biopharma-2017-07-17", "https://www.nasdaq.com/articles/repros-rprx-q2-earnings%3A-whats-in-store-for-the-stock-2017-08-01", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-july-14th-2017-07-14", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-arna-could-be-positioned-for-a-surge-2017-07-14", "https://www.nasdaq.com/articles/mid-day-market-update-yandex-jumps-following-announcement-deal-uber-amicus-therapeutics", "https://www.nasdaq.com/articles/pre-market-most-active-jul-13-2017-yndx-fold-snap-mt-aldr-arna-tef-qat-dal-tgt-qqq-teva", "https://www.nasdaq.com/articles/company-news-for-july-12-2017-2017-07-12", "https://www.nasdaq.com/articles/arena-announces-secondary-stock-offering-of-150m-shares-2017-07-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-arena-shoots-study-data-celg-inks-immuno-oncology-deal-2017-07-12", "https://www.nasdaq.com/articles/arena-announces-secondary-stock-worth-%24150m-revised-2017-07-17", "https://www.nasdaq.com/articles/midday-update-stocks-recover-after-spiraling-lower-trump-jr-emails-2017-07-11", "https://www.nasdaq.com/articles/mid-day-market-update-halcon-resources-jumps-after-announcing-sale-williston-basin-assets", "https://www.nasdaq.com/articles/arenas-ralinepag-positive-in-phase-ii-pah-study-shares-up-2017-07-11", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-flat-pepsico-profit-tops-expectations-2017-07-11", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-stock-bolting-higher-today-2017-07-11", "https://www.nasdaq.com/articles/stock-futures-turn-lower-oil-related-sell-europe-2017-07-11", "https://www.nasdaq.com/articles/pre-market-most-active-jul-11-2017-fold-hk-snap-shpg-gty-ocul-arna-rcii-pso-pep-wll-qqq", "https://www.nasdaq.com/articles/etrade-financial-statoil-arena-pharmaceuticals-johnson-johnson-and-united-therapeutics", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-snap-inc-snap-barracuda-networks-inc-cuda-and-arena", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2017-07-11", "https://www.nasdaq.com/articles/close-update-dow-flat-senate-recess-delay-offsets-email-sell-2017-07-11", "https://www.nasdaq.com/articles/health-care-sector-update-07112017-ocularnaneot-2017-07-11", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-arna-stock-skyrocketing-today-2017-07-11", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-15-voxx-international-shares-plummet-2017-07-11", "https://www.nasdaq.com/articles/health-care-sector-update-07112017-foldarnaneot-2017-07-11", "https://www.nasdaq.com/articles/best-buy-co-inc-bby-stock-and-retail-got-whacked.-heres-how-to-trade.-2017-07-11", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-snap-inc-snap-barracuda-networks-inc-cuda-and-arena", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-arena-pharmaceuticals-arna-stock-2017-07-05", "https://www.nasdaq.com/articles/4-marijuana-stocks-looking-combat-opioid-epidemic-2017-07-03", "https://www.nasdaq.com/articles/arena-ends-study-on-extended-release-formulation-of-pah-drug-2017-06-30", "https://www.nasdaq.com/articles/mid-day-market-update-bed-bath-beyond-drops-following-disappointing-earnings-synchronoss", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-flat-blackberry-sales-miss-views-2017-06-23", "https://www.nasdaq.com/articles/health-care-sector-update-07072017-cnatnvoarnadxtr-2017-07-07", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-arna-could-be-positioned-for-a-surge-2017-06-22", "https://www.nasdaq.com/articles/strength-seen-in-arena-pharmaceuticals-arna%3A-stock-up-5.4-2017-06-22", "https://www.nasdaq.com/articles/mid-afternoon-market-update-fang-drops-after-q1-results-invivo-therapeutics-shares-surge", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-gdxj-2017-06-19", "https://www.nasdaq.com/articles/why-is-arena-arna-up-15.1-since-the-last-earnings-report-2017-06-14", "https://www.nasdaq.com/articles/5-reasons-why-vivus-vvus-stock-should-be-in-your-portfolio-2017-05-24", "https://www.nasdaq.com/articles/better-know-marijuana-stock-arena-pharmaceuticals-2017-06-23", "https://www.nasdaq.com/articles/3-best-obesity-drug-stocks-buy-2017-2017-05-19", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-rose-much-183-today-2017-05-19", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-posts-q1-loss-revenues-down-2017-05-10", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q1-earnings%3A-whats-in-store-2017-05-04", "https://www.nasdaq.com/articles/arena-pharma-arna-down-after-underwritten-public-offering-2017-04-19", "https://www.nasdaq.com/articles/why-is-arena-pharmaceuticals-arna-down-11.3-since-the-last-earnings-report-2017-04-19", "https://www.nasdaq.com/articles/2-marijuana-stocks-rocketed-higher-double-digit-percentage-last-week-2017-05-23", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-goldman-sachs-earnings-miss-estimates-2017-04", "https://www.nasdaq.com/articles/mid-afternoon-market-update-gnc-gains-upbeat-earnings-barracuda-shares-drop-2017-04-18", "https://www.nasdaq.com/articles/tuesday-sector-laggards-shipping-drugs-2017-04-18", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-stock-slimmed-down-march-2017-04-10", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-6th-2017-04-06", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-posts-q4-earnings-revenues-up-2017-03-15", "https://www.nasdaq.com/articles/buy-facebook-inc-fb-stock-as-it-steals-snap-incs-snap-thunder-2017-03-15", "https://www.nasdaq.com/articles/mid-day-market-update-dow-drops-over-100-points-arena-pharmaceuticals-shares-plummet-2017", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-stock-surging-higher-today-2017-03-15", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-14-2017-htht-akao-cldx-fogo-nptn-arna-ccxi-kura-drrx", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-q4-earnings%3A-what-to-expect-2017-02-27", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-stock-sank-2016-2017-01-13", "https://www.nasdaq.com/articles/vivus-licenses-rights-to-pah-drugs-from-selten-pharma-2017-01-11", "https://www.nasdaq.com/articles/vertex-pharma-issues-disappointing-2017-orkambi-outlook-2017-01-09", "https://www.nasdaq.com/articles/puma-pbyi-expands-study-cohort-for-lead-candidate-pb272-2017-01-09", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-bank-of-america-corp-bac-arena-pharmaceuticals-inc.-arna", "https://www.nasdaq.com/articles/biogen-licenses-amunixs-xten-technology-for-factor-ix-drug-2017-01-06", "https://www.nasdaq.com/articles/health-care-sector-update-01052017-arnaetrmaezs-2017-01-05", "https://www.nasdaq.com/articles/arena-eisai-modify-marketing-supply-agreement-for-belviq-2017-01-05", "https://www.nasdaq.com/articles/evoke-diabetic-gastroparesis-drug-gimoti-positive-in-phase-iii-2017-01-05", "https://www.nasdaq.com/articles/allergan-agn-liletta-snda-accepted-for-review-in-the-u.s.-2017-01-05", "https://www.nasdaq.com/articles/bristol-myers-extends-deal-with-five-prime-therapeutics-2017-01-05", "https://www.nasdaq.com/articles/alexion-alxn-stock-up-on-10q-filing-2016-view-retained-2017-01-05", "https://www.nasdaq.com/articles/genocea-stock-up-on-positive-genital-herpes-infections-data-2017-01-06", "https://www.nasdaq.com/articles/alexion-alxn%3A-will-the-stock-continue-to-suffer-in-2017-2017-01-04", "https://www.nasdaq.com/articles/allergan-natrelle-inspira-breast-implants-approved-in-the-u.s.-2017-01-04", "https://www.nasdaq.com/articles/is-vertex-pharma-vrtx-poised-for-a-turnaround-in-2017-2017-01-03", "https://www.nasdaq.com/articles/sanofi-sny-closes-business-exchange-deal-with-boehringer-2017-01-03", "https://www.nasdaq.com/articles/vivus-vvus%3A-will-qsymia-stendra-sales-improve-in-2017-2017-01-03", "https://www.nasdaq.com/articles/tax-loss-selling-3-stocks-dump-right-now-2016-12-18", "https://www.nasdaq.com/articles/arena-arna-q3-loss-lower-than-expected-revenues-rise-2016-11-08", "https://www.nasdaq.com/articles/clovis-declares-pricing-of-upsized-offering-of-common-stock-2017-01-04", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-finally-showing-some-signs-life-2016-10-11", "https://www.nasdaq.com/articles/arena-arna-beacon-discovery-to-boost-research-platform-2016-09-02", "https://www.nasdaq.com/articles/actelion-aliof-uptravi-approved-for-pah-in-switzerland-2016-08-17", "https://www.nasdaq.com/articles/arenas-arna-q2-loss-narrower-revenues-increase-yy-2016-08-09", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-500-follow-through-indicator-126", "https://www.nasdaq.com/articles/arena-arna-q2-earnings-whats-store-stock-2016-08-01", "https://www.nasdaq.com/articles/company-news-for-july-20-2016-2016-07-20", "https://www.nasdaq.com/articles/arena-pharmaceuticals-shed-even-more-weight-october-2016-11-08", "https://www.nasdaq.com/articles/health-care-sector-update-07142016-rarearnarnva-2016-07-14", "https://www.nasdaq.com/articles/health-care-sector-update-07142016-vrxarnarnva-2016-07-14", "https://www.nasdaq.com/articles/arena-arna-cut-73-workforce-shifts-focus-pipeline-2016-07-01", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-arena-pharmaceuticals-inc.-arna-micron-technology-inc.-mu-and", "https://www.nasdaq.com/articles/health-care-sector-update-07012016-arnaarrymsli-2016-07-01", "https://www.nasdaq.com/articles/orexigen-stock-gains-more-50-markman-hearing-2016-06-09", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-shares-march-higher-can-it-continue-2016-06-01", "https://www.nasdaq.com/articles/health-care-sector-update-07192016-arnaceruscln-2016-07-19", "https://www.nasdaq.com/articles/health-care-sector-update-07142016-rarearnarnva-2016-07-14", "https://www.nasdaq.com/articles/health-care-sector-update-07142016-vrxarnarnva-2016-07-14", "https://www.nasdaq.com/articles/arena-arna-cut-73-workforce-shifts-focus-pipeline-2016-07-01", "https://www.nasdaq.com/articles/drug-stocks-reporting-early-next-week-teva-arna-more-2016-05-06", "https://www.nasdaq.com/articles/arena-arna-q1-earnings-whats-store-stock-2016-05-04", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-21st-2016-04-21", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-13th-2016-04-13", "https://www.nasdaq.com/articles/little-known-reason-arena-pharmaceuticals-could-be-winner-2016-06-01", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-alcoa-revenue-misses-views-2016-04-12", "https://www.nasdaq.com/articles/stock-futures-buoyed-higher-oil-shrugging-downbeat-alcoa-earnings-2016-04-12", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-45-horizon-pharma-shares-tumble-2016-04-12", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-rides-celgenes-coattails-big-gains-march-2016-04-08", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-april-7th-2016-04-07", "https://www.nasdaq.com/articles/biotech-investing-guide-3-stocks-buy-and-3-avoid-2016-03-11", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-8th-2016-03-08", "https://www.nasdaq.com/articles/arena-arna-gains-pain-drug-positive-in-early-stage-study-2016-04-13", "https://www.nasdaq.com/articles/arenas-arna-q4-loss-narrower-revenues-fall-short-2016-03-01", "https://www.nasdaq.com/articles/will-arena-arna-post-narrower-expected-4q-loss-2016-02-26", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-lost-17-its-value-january-2016-02-09", "https://www.nasdaq.com/articles/arena-boehringer-ingelheim-ink-deal-schizophrenia-in-focus-2016-01-13", "https://www.nasdaq.com/articles/genomic-health-down-on-bleak-preliminary-q4-15-results-2016-01-11", "https://www.nasdaq.com/articles/myriad-genetics%3A-urologic-cancer-assays-positive-in-trials-2016-01-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-ends-2015-sour-note-can-it-recover-2016-2016-01-07", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-4th-2016-03-04", "https://www.nasdaq.com/articles/arenas-arna-q4-loss-narrower-revenues-fall-short-2016-03-01", "https://www.nasdaq.com/articles/teva-active-biotech-halt-high-doses-of-laquinimod-for-ms-2016-01-05", "https://www.nasdaq.com/articles/pfizer-merck-kgaa-partner-with-syndax-for-ovarian-cancer-2016-01-05", "https://www.nasdaq.com/articles/pluristem-therapeutics-psti-in-focus%3A-stock-rises-14.1-2016-01-04", "https://www.nasdaq.com/articles/worst-3-biotech-stocks-2016-2015-12-30", "https://www.nasdaq.com/articles/anika-anik-starts-enrolment-in-phase-iii-hyalofast-study-2015-12-30", "https://www.nasdaq.com/articles/cel-sci-corp-cvm-shows-strength-stock-moves-83-2016-01-07", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-29th-2015-12-29", "https://www.nasdaq.com/articles/actelions-uptravi-approved-in-the-u.s.-for-pah-treatment-2015-12-23", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-22nd-2015-12-22", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-18th-2015-12-18", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-14th-2015-12-14", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-arna-could-beat-earnings-estimates-again-2015-12-14", "https://www.nasdaq.com/articles/orexigen-therapeutics-stock-dropped-28-november-can-it-recover-2015-12-08", "https://www.nasdaq.com/articles/epizymes-tazemetostat-ind-application-accepted-for-dlbcl-2015-12-29", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-7th-2015-12-07", "https://www.nasdaq.com/articles/orexigen-therapeutics-incs-stock-loses-weight-downgrade-2015-12-04", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-inc-bulked-november-2015-12-04", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-3rd-2015-12-03", "https://www.nasdaq.com/articles/why-axovant-sciences-skyrocketed-56-november-2015-12-03", "https://www.nasdaq.com/articles/can-the-rally-in-arena-pharmaceuticals-arna-shares-continue-2015-12-02", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-stock-briefly-spiked-today-2015-12-01", "https://www.nasdaq.com/articles/bluebird-bio-crashes-after-clinical-trial-update-2015-12-07", "https://www.nasdaq.com/articles/arena-arnaeisais-belviq-xr-nda-accepted-review-2015-12-01", "https://www.nasdaq.com/articles/how-arena-pharma-arna-stock-stands-out-in-a-strong-industry-2015-11-30", "https://www.nasdaq.com/articles/why-ambarella-arena-pharmaceuticals-and-itc-holdings-jumped-today-2015-11-30", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-november-23rd-2015-11-23", "https://www.nasdaq.com/articles/3-dangerous-stocks-2015-11-12", "https://www.nasdaq.com/articles/arena-3q-loss-narrower-expected-belviq-focus-2015-11-11", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-429-follow-through-indicator-123", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-1st-2015-12-01", "https://www.nasdaq.com/articles/why-orexigen-therapeutics-incs-stock-losing-weight-today-2015-11-06", "https://www.nasdaq.com/articles/3-things-you-never-knew-about-medicare-2015-11-02", "https://www.nasdaq.com/articles/heres-why-arena-pharmaceuticals-inc-struggling-today-2015-10-30", "https://www.nasdaq.com/articles/will-arenas-arna-q3-loss-be-narrower-expected-2015-10-30", "https://www.nasdaq.com/articles/whats-behind-arena-pharmaceuticals-volatility-lately-2015-10-17", "https://www.nasdaq.com/articles/why-zafgen-plummeted-today-2015-10-16", "https://www.nasdaq.com/articles/3-investing-myths-debunked-2015-09-18", "https://www.nasdaq.com/articles/after-hours-earnings-report-november-10-2015-dox-kgc-htht-exel-ingn-nvgs-pnnt-opwr-arna", "https://www.nasdaq.com/articles/2-questions-investors-need-ask-about-biogens-latest-deal-2015-09-10", "https://www.nasdaq.com/articles/arena-pharmaceuticals-lost-third-its-value-august-heres-why-2015-09-05", "https://www.nasdaq.com/articles/3-battleground-biotech-stocks-i-would-avoid-all-costs-2015-08-28", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-rises%3A-stock-adds-5.7-in-session-2015-08-24", "https://www.nasdaq.com/articles/3-most-disappointing-drug-launches-all-time-2015-08-23", "https://www.nasdaq.com/articles/bull-or-bear-biotechs-post-earnings-buys-and-sells-2015-08-23", "https://www.nasdaq.com/articles/arena-pharmaceuticals-belviq-sales-are-better-they-appear-theyre-still-not-great-2015-08", "https://www.nasdaq.com/articles/why-hasnt-orexigen-launched-its-obesity-drug-europe-yet-2015-09-18", "https://www.nasdaq.com/articles/arena-pharmaceuticals-slims-down-after-its-q2-report-2015-08-06", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-arena-pharmaceuticals-arna-this-earnings-season-tale-of-the-tape", "https://www.nasdaq.com/articles/will-arena-pharmaceuticals-arna-surprise-q2-earnings-analyst-blog-2015-08-04", "https://www.nasdaq.com/articles/celgene-buys-receptos-arena-pharmaceuticals-next-2015-07-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-bank-america-tops-q2-views-2015-07-15", "https://www.nasdaq.com/articles/obesity-statistics-take-wrong-turn-latest-study-2015-07-05", "https://www.nasdaq.com/articles/3-biotech-stocks-i-wont-buy-2015-06-13", "https://www.nasdaq.com/articles/arena-pharmaceuticals-2q-loss-narrower-expected-analyst-blog-2015-08-06", "https://www.nasdaq.com/articles/orexigen-therapeutics-inc-goes-biotech-beauty-dreadful-drugmaker-2015-05-16", "https://www.nasdaq.com/articles/which-these-growth-stocks-most-worthy-your-money-2015-05-16", "https://www.nasdaq.com/articles/why-shares-orexigen-therapeutics-inc-cratered-today-2015-05-13", "https://www.nasdaq.com/articles/arena-pharmaceuticals-1q-loss-narrower-expected-analyst-blog-2015-05-12", "https://www.nasdaq.com/articles/why-its-lights-out-orexigen-therapeutics-inc-2015-05-12", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-429-follow-through-indicator-112", "https://www.nasdaq.com/articles/will-arena-pharmaceuticals-arna-surprise-earnings-analyst-blog-2015-05-07", "https://www.nasdaq.com/articles/obesity-drugs-stocks-watch-2015-06-09", "https://www.nasdaq.com/articles/arena-pharmaceuticals-incs-plan-win-obesity-drug-war-2015-04-24", "https://www.nasdaq.com/articles/orexigens-obesity-drug-contrave-faces-generic-threat-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-tuesday-tale-of-the-tape-2015-04-21", "https://www.nasdaq.com/articles/3-promising-small-caps-under-10-you-can-buy-right-now-2015-04-21", "https://www.nasdaq.com/articles/3-promising-healthcare-stocks-under-10-2015-04-15", "https://www.nasdaq.com/articles/arena-eisai-finish-phase-i-studies-on-obesity-drug-belviq-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/best-stock-invest-obesity-drugs-2015-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-04292015-arnaoncyig-2015-04-29", "https://www.nasdaq.com/articles/arena-pharmaceuticals-up-on-belviqs-new-patent-approval-analyst-blog-2015-04-08", "https://www.nasdaq.com/articles/calls-look-ride-arena-pharma-2015-04-08", "https://www.nasdaq.com/articles/arna-crosses-below-key-moving-average-level-2015-03-24", "https://www.nasdaq.com/articles/biotech-stocks-2-avoid-1-buy-2015-03-22", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-thursday-tale-of-the-tape-2015-03-19", "https://www.nasdaq.com/articles/too-good-be-true-proceed-caution-these-2-biotechs-2015-03-14", "https://www.nasdaq.com/articles/after-hours-most-active-mar-12-2015-cy-intc-pfe-f-csco-fxcm-bac-aray-arna-wmb-axp-nvda", "https://www.nasdaq.com/articles/health-care-sector-update-04102015-arna-vrtx-anip-2015-04-10", "https://www.nasdaq.com/articles/novo-nordisks-saxenda%3A-new-data-from-phase-iiia-study-analyst-blog-2015-03-09", "https://www.nasdaq.com/articles/could-surprising-drug-stop-heart-attacks-they-happen-2015-03-08", "https://www.nasdaq.com/articles/why-orexigen-therapeutics-inc-stock-exploded-higher-2015-03-03", "https://www.nasdaq.com/articles/arena-pharmaceuticals-q4-loss-wider-than-expected-analyst-blog-2015-03-03", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-inc-burst-today-2015-03-03", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc-earnings-explaining-wonky-trends-2015-03-02", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-429-follow-through-indicator-108", "https://www.nasdaq.com/articles/zacks-rank-5-additions-for-wednesday-tale-of-the-tape-2015-03-11", "https://www.nasdaq.com/articles/orexigen-therapeutics-inc-gives-skinny-its-drug-launch-2015-02-26", "https://www.nasdaq.com/articles/arna-crosses-above-key-moving-average-level-2015-02-18", "https://www.nasdaq.com/articles/dont-worry-about-orexigens-obesity-drug-eu-approval-2015-02-10", "https://www.nasdaq.com/articles/forget-about-ebola-stocks-and-invest-instead-2015-02-09", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-inc-shares-jumped-24-january-2015-02-06", "https://www.nasdaq.com/articles/despite-cdcs-best-efforts-disease-just-hit-record-levels-2015-02-02", "https://www.nasdaq.com/articles/newly-approved-weight-loss-method-works-tricking-your-brain-2015-01-25", "https://www.nasdaq.com/articles/will-arena-pharmaceuticals-arna-disappoint-on-q4-earnings-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-surge-netflix-shares-jump-upbeat-earnings-2015-01-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mixed-unitedhealth-profit-tops-expectations-2015-01-21", "https://www.nasdaq.com/articles/pre-market-most-active-jan-21-2015-sune-ul-sne-rbs-nflx-alny-arna-mtu-tvix-aapl-bac-qcom", "https://www.nasdaq.com/articles/mid-afternoon-market-update-alnylam-pharmaceuticals-drops-following-equity-offering", "https://www.nasdaq.com/articles/forget-pills-could-device-put-end-obesity-america-2015-01-17", "https://www.nasdaq.com/articles/arena-pharmaceuticals-doses-for-cardiovascular-study-analyst-blog-2015-01-16", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-arena-pharma-arna-tale-of-the-tape-2015-01-15", "https://www.nasdaq.com/articles/arena-pharmaceuticals-to-raise-fund-via-share-issuance-analyst-blog-2015-01-22", "https://www.nasdaq.com/articles/why-vivus-inc-stock-descended-14-december-2015-01-09", "https://www.nasdaq.com/articles/pre-market-most-active-jan-9-2015-san-mpw-qqq-tvix-bac-cnat-xiv-alu-aapl-arna-skm-pbr-2015", "https://www.nasdaq.com/articles/history-suggests-mannkind-corporations-afrezza-could-already-be-doomed-2015-01-09", "https://www.nasdaq.com/articles/arna-february-27th-options-begin-trading-2015-01-08", "https://www.nasdaq.com/articles/pre-market-most-active-jan-8-2015-alu-bind-pbra-san-pbr-tvix-xiv-bac-abev-arna-aapl-siri", "https://www.nasdaq.com/articles/arena-pharmaceuticals-soars-on-positive-study-results-analyst-blog-2015-01-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-incs-phase-1-data-worth-550-million-2015-01-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-in-focus%3A-stock-falls-5.7-tale-of-the-tape-2015-01-12", "https://www.nasdaq.com/articles/why-shares-arena-pharmaceuticals-inc-skyrocketed-today-2015-01-07", "https://www.nasdaq.com/articles/health-care-sector-update-01072015-rptp-arna-casm-2015-01-07", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-jumps-over-200-points-after-fed-minutes-rpm-shares-drop", "https://www.nasdaq.com/articles/mid-day-market-update-j-c-penney-jumps-strong-holiday-sales-micron-shares-decline-2015-01", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-inc-stock-slumped-17-december-2015-01-06", "https://www.nasdaq.com/articles/newest-fda-approved-obesity-drug-also-oldest-2014-12-27", "https://www.nasdaq.com/articles/3-stocks-poised-eye-popping-gains-2015-2014-12-27", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-surge-monsanto-profit-tops-estimates-2015-01-07", "https://www.nasdaq.com/articles/novo-nordisks-saxenda-gets-fda-nod-launch-in-1h15-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/new-obesity-drug-available-soon-2014-12-21", "https://www.nasdaq.com/articles/growing-concern-accounts-nearly-500000-cancer-cases-each-year-2014-12-07", "https://www.nasdaq.com/articles/could-company-follow-dendreons-footsteps-2014-12-03", "https://www.nasdaq.com/articles/why-orexigen-therapeutics-inc-stock-rocketed-43-higher-november-2014-12-03", "https://www.nasdaq.com/articles/obesity-drug-europe-trumps-us-2014-11-17", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-shares-march-higher-can-it-continue-tale-of-the-tape-2014-11-13", "https://www.nasdaq.com/articles/3-biotech-stocks-i-dont-want-christmas-2014-12-24", "https://www.nasdaq.com/articles/why-orexigen-therapeutics-inc-stock-skyrocketed-2014-11-10", "https://www.nasdaq.com/articles/arena-pharmaceuticals-posts-in-line-q3-loss-belviq-grows-analyst-blog-2014-11-04", "https://www.nasdaq.com/articles/will-arena-pharma-arna-q3-loss-be-wider-than-expected-analyst-blog-2014-10-31", "https://www.nasdaq.com/articles/could-arena-pharmaceuticals-inc-be-running-out-money-2014-10-22", "https://www.nasdaq.com/articles/3-biotech-stocks-near-52-week-lows-worth-buying-2014-10-08", "https://www.nasdaq.com/articles/1-biotech-stock-im-definitely-not-buying-2014-10-07", "https://www.nasdaq.com/articles/why-sanofi-betting-mannkind-corporations-afrezza-2014-10-06", "https://www.nasdaq.com/articles/can-arena-pharmaceuticals-inc-overcome-belviqs-slow-launch-2014-11-11", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc.-arna-jumps%3A-stock-rises-9.5-tale-of-the-tape-2014-09-19", "https://www.nasdaq.com/articles/nasdaq-biotech-top-performers-pre-open-september-19-2014-09-19", "https://www.nasdaq.com/articles/3-biotechs-investors-should-watch-2014-09-19", "https://www.nasdaq.com/articles/why-vivus-inc-todays-best-biotech-stock-2014-09-18", "https://www.nasdaq.com/articles/5-things-arena-pharmaceuticals-incs-management-wants-you-know-2014-09-17", "https://www.nasdaq.com/articles/2-new-diet-drugs-coming-soon-2014-09-13", "https://www.nasdaq.com/articles/surprising-new-competitor-should-arena-pharmaceuticals-inc-and-orexigen-therapeutics-inc", "https://www.nasdaq.com/articles/vivus-inc-short-sell-2014-10-04", "https://www.nasdaq.com/articles/why-arena-pharmaceuticals-inc-stock-crashed-31-2014-2014-09-09", "https://www.nasdaq.com/articles/arena-pharmaceuticals-apd811-gets-orphan-drug-status-analyst-blog-2014-09-03", "https://www.nasdaq.com/articles/3-simple-ways-invest-george-soros-2014-08-30", "https://www.nasdaq.com/articles/biotech-investing-3-ways-youre-doing-it-wrong-2014-08-24", "https://www.nasdaq.com/articles/arena-pharmaceuticals-falls-on-wider-than-expected-q2-loss-analyst-blog-2014-08-04", "https://www.nasdaq.com/articles/september-12th-options-now-available-arena-pharmaceuticals-arna-2014-07-31", "https://www.nasdaq.com/articles/sector-update-health-care-stocks-flat-pre-market-2014-07-21", "https://www.nasdaq.com/articles/fda-approves-orexigen-therapeutics-incs-goldilocks-obesity-drug-2014-09-11", "https://www.nasdaq.com/articles/arena-pharmaceuticals-pain-candidate-gets-new-u.s.-patent-analyst-blog-2014-07-16", "https://www.nasdaq.com/articles/arena-pharmaceuticals-eisai-boost-obesity-drug-sales-force-analyst-blog-2014-07-11", "https://www.nasdaq.com/articles/company-news-for-july-08-2014-corporate-summary-2014-07-08", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-in-focus%3A-stock-slumps-9.4-tale-of-the-tape-2014-07-08", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-iyy-2014-07-07", "https://www.nasdaq.com/articles/mondays-etf-movers-fm-xbi-2014-07-07", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-arna-2014-06-11", "https://www.nasdaq.com/articles/sector-update-health-care-2014-07-21-0", "https://www.nasdaq.com/articles/july-3rd-options-now-available-arena-pharmaceuticals-arna-2014-05-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-celldex-incyte-tie-big-pharma-immuno-oncology-analyst-blog-2014-05", "https://www.nasdaq.com/articles/fda-panel-to-review-novo-nordisks-victoza-3mg-analyst-blog-2014-05-21", "https://www.nasdaq.com/articles/first-week-arna-august-16th-options-trading-2014-05-20", "https://www.nasdaq.com/articles/arena-slides-on-wider-q1-loss-misses-ests-analyst-blog-2014-05-15", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-500-follow-through-indicator-119", "https://www.nasdaq.com/articles/after-hours-earnings-report-may-12-2014-mck-trq-bwc-rax-pgh-mnkd-trak-cvg-pky-arna-dxpe", "https://www.nasdaq.com/articles/july-25th-options-now-available-arena-pharmaceuticals-arna-2014-06-05", "https://www.nasdaq.com/articles/arna-crosses-below-key-moving-average-level-2014-04-10", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-may-30th-2014-04-10", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-may-23rd-2014-04-03", "https://www.nasdaq.com/articles/arna-crosses-below-key-moving-average-level-2014-03-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-intermune-grabs-headlines-impressive-data-analyst-blog-2014-03-05", "https://www.nasdaq.com/articles/company-news-for-march-03-2014-corporate-summary-2014-03-03", "https://www.nasdaq.com/articles/interesting-arna-put-and-call-options-june-6th-2014-04-24", "https://www.nasdaq.com/articles/earnings-reaction-history-arena-pharmaceuticals-inc-600-follow-through-indicator-47", "https://www.nasdaq.com/articles/premarket-primer-friday-february-14-turnaround-2014-02-14", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-regeneron-rises-4-phase-3-trial-eylea-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-02-10-1", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-in-focus%3A-stock-rallies-7.2-tale-of-the-tape-2014-01-16", "https://www.nasdaq.com/articles/fda-action-date-for-orexigens-contrave-analyst-blog-2014-01-08", "https://www.nasdaq.com/articles/ariad-pharmaceuticals-aria-worth-watching%3A-stock-surges-19.7-tale-of-the-tape-2013-12-19", "https://www.nasdaq.com/articles/arena-posts-wider-loss-misses-ests-analyst-blog-2014-02-28", "https://www.nasdaq.com/articles/arena-pharmaceuticals-arna-worth-a-look%3A-stock-surges-10.6-tale-of-the-tape-2013-11-12", "https://www.nasdaq.com/articles/arena-pharma-q3-loss-narrower-than-expected-analyst-blog-2013-11-08", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-11-08-0", "https://www.nasdaq.com/articles/vivus-loss-in-line-with-ests-shares-fall-analyst-blog-2013-11-07", "https://www.nasdaq.com/articles/should-you-worry-about-the-short-interest-in-arena-pharmaceuticals-inc.-arna-tale-of-the", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc.-enters-oversold-territory-tale-of-the-tape-2013-10-18", "https://www.nasdaq.com/articles/arena-to-double-belviq-sales-force-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/vivus-shares-up-marginally-post-sanofi-deal-analyst-blog-2013-12-17", "https://www.nasdaq.com/articles/obesity-drug-makers-vivus-and-arena-just-cant-seem-lighten-2013-10-10", "https://www.nasdaq.com/articles/update-on-orexigens-contrave-analyst-blog-2013-10-08", "https://www.nasdaq.com/articles/stock-upgrades-apple-hain-celestial-and-signet-jewelers-2013-10-07", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-over-100-points-active-network-shares-jump-2013-09-30", "https://www.nasdaq.com/articles/whats-weighing-obesity-drug-makers-vivus-and-arena-2013-09-26", "https://www.nasdaq.com/articles/vivus-hopes-tied-to-qsymia-analyst-blog-2013-09-25", "https://www.nasdaq.com/articles/update-on-arena-eisais-belviq-analyst-blog-2013-09-18", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-slip-citigroup-profit-misses-estimates-2013-10-15", "https://www.nasdaq.com/articles/after-hours-most-active-sep-11-2013-bac-intc-kkr-bx-tsrx-nok-qcom-rio-pva-siri-msft-arna", "https://www.nasdaq.com/articles/vivus-gets-a-new-ceo-analyst-blog-2013-09-09", "https://www.nasdaq.com/articles/pipeline-at-arena-pharma-advances-analyst-blog-2013-08-30", "https://www.nasdaq.com/articles/loss-widens-at-vivus-analyst-blog-2013-08-07", "https://www.nasdaq.com/articles/arena-pharmas-q2-earnings-soar-analyst-blog-2013-08-05", "https://www.nasdaq.com/articles/pre-market-most-active-aug-1-2013-dell-jcp-bac-sune-fb-alu-sxc-bcrx-xom-arna-myl-halo-2013", "https://www.nasdaq.com/articles/arena-pharma-cy-biotech-unite-for-belviq-analyst-blog-2013-07-29", "https://www.nasdaq.com/articles/after-hours-most-active-sep-12-2013-so-c-mo-dow-wag-rio-arna-intc-ulta-qqq-msft-splk-2013", "https://www.nasdaq.com/articles/better-access-to-vivus-qsymia-analyst-blog-2013-07-03", "https://www.nasdaq.com/articles/arena-seeks-canadian-approval-for-belviq-analyst-blog-2013-06-28", "https://www.nasdaq.com/articles/healthcare-stocks-inching-lower-weight-loss-drug-makers-climbing-after-ama-labels-obesity", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-06-19-0", "https://www.nasdaq.com/articles/pre-market-most-active-jun-12-2013-ctb-nct-wday-bac-vod-s-nok-gt-grfs-arna-siri-clvs-2013", "https://www.nasdaq.com/articles/market-wrap-tuesday-may-28-bull-run-continues-economic-data-sparks-another-rally-2013-05", "https://www.nasdaq.com/articles/arna-sheds-light-on-belviq-launch-analyst-blog-2013-05-09", "https://www.nasdaq.com/articles/vivus-appoints-new-ceo-analyst-blog-2013-07-23", "https://www.nasdaq.com/articles/arena-pharma-narrows-loss-analyst-blog-2013-05-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-surge-jobs-data-dow-breaks-15000-first-time-history-2013", "https://www.nasdaq.com/articles/pre-market-most-active-may-3-2013-cetv-bac-arna-spil-fb-qqq-aig-nvs-db-siri-nok-abx-2013", "https://www.nasdaq.com/articles/market-wrap-friday-may-3-stocks-jump-strong-jobs-data-2013-05-03", "https://www.nasdaq.com/articles/after-hours-most-active-may-2-2013-qqq-aig-lnkd-amx-arna-fb-nct-nct-nrz-nwsa-msft-dtv-2013", "https://www.nasdaq.com/articles/weekly-preview-focus-shifts-earnings-economy-2013-04-26", "https://www.nasdaq.com/articles/best-stocks-biotech-still-holding-top-spots-2013-04-22", "https://www.nasdaq.com/articles/pre-market-most-active-may-8-2013-bip-bac-cie-bbry-vclk-vntv-tlk-cfx-soda-arna-siri-fb", "https://www.nasdaq.com/articles/patients-dosed-in-arena-study-analyst-blog-2013-04-09", "https://www.nasdaq.com/articles/weekly-cfo-sells-highlight-znga-arna-jack-tumi-panw-2013-04-07", "https://www.nasdaq.com/articles/arna-eisais-belviq-filed-in-mexico-analyst-blog-2013-04-03", "https://www.nasdaq.com/articles/vivus-opts-for-royalty-financing-analyst-blog-2013-04-02", "https://www.nasdaq.com/articles/loss-orex-narrower-expected-analyst-blog-2013-03-14", "https://www.nasdaq.com/articles/arena-cuts-loss-misses-estimates-analyst-blog-2013-03-08", "https://www.nasdaq.com/articles/company-news-for-march-05-2013-corporate-summary-2013-03-05", "https://www.nasdaq.com/articles/expanded-access-for-vivus-qsymia-analyst-blog-2013-04-18", "https://www.nasdaq.com/articles/vivus-reports-wider-loss-analyst-blog-2013-02-26", "https://www.nasdaq.com/articles/chmp-still-negative-on-vivus-qsiva-analyst-blog-2013-02-22", "https://www.nasdaq.com/articles/discovery-laboratories-innovative-financing-catalyst-buy-stock-2013-02-14", "https://www.nasdaq.com/articles/vivus-unveils-qsymia-study-results-analyst-blog-2013-02-07", "https://www.nasdaq.com/articles/arena-falters-on-belviq-eu-approval-analyst-blog-2013-01-23", "https://www.nasdaq.com/articles/pre-market-most-active-jan-22-2013-snv-vod-rimm-bac-sny-bcs-vz-arna-fb-nok-aapl-dell-2013", "https://www.nasdaq.com/articles/update-on-orexigens-contrave-analyst-blog-2013-01-10", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-4-2013-rig-ssys-tecd-arna-cel-byd-yge-alvr-2013-03-01", "https://www.nasdaq.com/articles/takeda-terminates-amylin-agreement-analyst-blog-2012-12-31", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-celg-vvus-2012-12-12", "https://www.nasdaq.com/articles/3-bio-pharmas-trades-offering-good-upside-potential-2012-11-21", "https://www.nasdaq.com/articles/arena-cuts-loss-affirms-sales-view-analyst-blog-2012-11-09", "https://www.nasdaq.com/articles/vivus-misses-3q-estimates-analyst-blog-2012-11-08", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-gild-vvus-2012-10-25", "https://www.nasdaq.com/articles/chmp-negative-on-vivus-qsiva-analyst-blog-2012-10-22", "https://www.nasdaq.com/articles/best-2012-small-caps-2013-01-04", "https://www.nasdaq.com/articles/arena-pharma-initiates-pah-study-analyst-blog-2012-10-15", "https://www.nasdaq.com/articles/vivus-expects-european-setback-analyst-blog-2012-09-25", "https://www.nasdaq.com/articles/right-data-key-spotting-trends-2012-09-21", "https://www.nasdaq.com/articles/pre-market-most-active-sep-21-2012-bac-orcl-fb-vvus-qqq-siri-nok-bcs-s-arna-kbh-ai-2012-09", "https://www.nasdaq.com/articles/vivus-launches-obesity-drug-qsymia-analyst-blog-2012-09-20", "https://www.nasdaq.com/articles/investing-biotech-stocks-journey-profits-requires-good-gps-2012-08-31", "https://www.nasdaq.com/articles/after-hours-most-active-aug-31-2012-qqq-mo-arr-mrk-bac-ctl-exel-nihd-esv-intc-siri-arna", "https://www.nasdaq.com/articles/short-interest-swings-biotech-stocks-biib-celg-gild-2012-10-15", "https://www.nasdaq.com/articles/arena-pharma-initiates-pah-study-analyst-blog-2012-10-15", "https://www.nasdaq.com/articles/arena-cuts-loss-sales-climb-analyst-blog-2012-08-14", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc.-enters-oversold-territory-tale-of-the-tape-2012-08-01", "https://www.nasdaq.com/articles/arena-pharmaceuticals-inc.enters-oversold-territory-tale-of-the-tape-2012-07-20", "https://www.nasdaq.com/articles/pre-market-most-active-jul-18-2012-bac-vvus-san-agnc-arna-bhp-tot-orex-eric-qqq-rio-sbh", "https://www.nasdaq.com/articles/glory-for-vivus-after-arena-analyst-blog-2012-07-18", "https://www.nasdaq.com/articles/pre-market-most-active-aug-29-2012-san-nok-eric-bac-mcp-tia-joy-qqq-arna-tfm-wmgi-ebay", "https://www.nasdaq.com/articles/arena-seeks-approval-in-switzerland-analyst-blog-2012-07-13", "https://www.nasdaq.com/articles/pre-market-most-active-jul-13-2012-jpm-bac-two-qqq-wfc-bp-tot-infy-vvus-arna-fb-gmcr-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jul-11-2012-bzh-un-qqq-bac-bud-arna-cys-psec-ubs-orex-eric-siri", "https://www.nasdaq.com/articles/pre-market-most-active-jul-9-2012-siri-agp-qqq-bac-sto-wlp-arna-wcg-tsm-spil-fb-twtc-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jul-6-2012-bac-sap-arna-qqq-infa-fb-aapl-stx-2012-07-06", "https://www.nasdaq.com/articles/pre-market-most-active-jul-3-2012-bcs-un-sny-azn-modl-bac-nok-nsph-arna-qqq-msft-aapl-2012", "https://www.nasdaq.com/articles/second-time-lucky-for-arenas-belviq-analyst-blog-2012-06-29", "https://www.nasdaq.com/articles/pre-market-most-active-jul-16-2012-hgsi-c-bac-prx-tot-qqq-ntt-siri-fte-orex-arna-asml-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-28-2012-bac-bcs-jpm-arna-vrtx-nok-orex-c-etp-ebay-fb-qqq-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-27-2012-eric-amrn-bac-fb-abb-jnj-tkc-nok-omer-arna-nvo-znga", "https://www.nasdaq.com/articles/after-hours-most-active-jun-27-2012-qqq-sle-bac-extr-qnst-centa-gxp-arna-wm-vsh-vrsn-aet", "https://www.nasdaq.com/articles/pre-market-most-active-jun-26-2012-nok-bac-pc-tkc-sdrl-asml-arna-stx-nj-nwsa-znga-vod-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-25-2012-tia-arna-qsft-fb-qqq-asml-rimm-2012-06-25", "https://www.nasdaq.com/articles/pre-market-most-active-jun-22-2012-bac-arna-cs-asml-rdsa-ms-sdrl-fb-abb-znga-qqq-tsla-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-21-2012-sunh-onxx-celg-bac-arna-jnj-vod-asx-bhp-ing-bp-gnmk", "https://www.nasdaq.com/articles/pre-market-most-active-jun-29-2012-elt-bac-nok-f-rimm-qqq-bcs-bp-vod-armh-aapl-arna-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-19-2012-bac-wag-orcl-e-nok-eric-asml-arna-qqq-wes-aapl-jcp-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-18-2012-bac-bhp-gsk-cs-nok-caj-arna-qqq-fb-znga-spil-msft-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-15-2012-bac-nok-arna-mt-armh-bp-qqq-znga-fb-bcs-c-aapl-2012-06", "https://www.nasdaq.com/articles/after-hours-most-active-jun-15-2012-bac-fb-kgc-io-intc-qqq-nwsa-abx-spf-gg-dell-arna-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-14-2012-nok-bac-qsft-ddd-ivn-rdsa-un-qqq-dndn-arna-vod-znga", "https://www.nasdaq.com/articles/pre-market-most-active-jun-13-2012-jnj-bac-tfm-arna-mt-cjcl-qqq-znga-abb-fslr-asml-sto", "https://www.nasdaq.com/articles/pre-market-most-active-jun-12-2012-bac-tia-kors-kt-pc-nok-qqq-armh-arna-aapl-msft-znga", "https://www.nasdaq.com/articles/pre-market-most-active-jun-20-2012-bac-vod-nok-bhp-bona-ing-gsk-arna-pg-qsft-adbe-idix", "https://www.nasdaq.com/articles/pre-market-most-active-jun-19-2012-bac-wag-orcl-e-nok-eric-asml-arna-qqq-wes-aapl-jcp-2012", "https://www.nasdaq.com/articles/pre-market-most-active-may-22-2012-qqq-nok-fb-bby-tef-bac-sny-nvo-vod-aapl-arna-znga-2012", "https://www.nasdaq.com/articles/strongest-small-caps-market-2012-05-21", "https://www.nasdaq.com/articles/pre-market-most-active-may-17-2012-sny-bac-bud-mt-mtl-wmt-qqq-vod-aapl-dndn-znga-arna-2012", "https://www.nasdaq.com/articles/pre-market-most-active-may-16-2012-ctl-sny-bac-ge-nct-mt-qqq-arna-sina-petd-znga-rimm-2012", "https://www.nasdaq.com/articles/after-hours-most-active-may-15-2012-dfg-tpx-jcp-gsm-qqq-bac-arna-ccj-aig-velt-intc-nwsa", "https://www.nasdaq.com/articles/pre-market-most-active-may-14-2012-bac-chk-nok-bbva-cs-siri-jpm-arna-qqq-yhoo-aapl-fran", "https://www.nasdaq.com/articles/pre-market-most-active-jun-11-2012-bac-duk-pgn-nok-qqq-c-std-aapl-fb-vod-arna-znga-2012-06", "https://www.nasdaq.com/articles/pre-market-most-active-may-8-2012-bac-siri-tef-arna-aig-fosl-bcs-ihg-qqq-fte-gtxi-mako", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2012-05-07", "https://www.nasdaq.com/articles/arena-pharma-drug-under-eu-review-analyst-blog-2012-03-27", "https://www.nasdaq.com/articles/company-news-for-march-27-2012-corporate-summary-2012-03-27", "https://www.nasdaq.com/articles/how-qnexas-positive-panel-review-generated-alpha-short-sellers-2012-02-23", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2012-01-26", "https://www.nasdaq.com/articles/pre-market-most-active-may-11-2012-jpm-arna-nvda-qqq-siri-wwww-aapl-2012-05-11", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-2012-01-17", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-01-11", "https://www.nasdaq.com/articles/arena-pharma-files-response-to-crl-analyst-blog-2012-01-06", "https://www.nasdaq.com/articles/stocks-mixed-commodities-slip-gdp-data-raises-concern-over-economy-2011-05-26", "https://www.nasdaq.com/articles/mid-day-update-stocks-mixed-sessions-half-gdp-employment-data-weigh-2011-05-26", "https://www.nasdaq.com/articles/opening-view-djia-spx-set-extend-upward-momentum-msft-thc-atvi-radar-2011-05-10", "https://www.nasdaq.com/articles/what-large-call-buyer-sees-arena-2011-01-25", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-monday-tale-of-the-tape-2012-01-23", "https://www.nasdaq.com/articles/options-trade-day-orexigen-therapeutics-bull-call-spread-2010-11-22", "https://www.nasdaq.com/articles/stocks-higher-mid-day-trading-investors-eye-housing-data-g-20-earnings-2010-10-25", "https://www.nasdaq.com/articles/mid-day-update-stocks-solidly-higher-new-housing-data-adds-positive-sentiment-2010-10-25", "https://www.nasdaq.com/articles/looking-value-septembers-biggest-losers-2010-10-04", "https://www.nasdaq.com/articles/what-analysts-wont-tell-you-about-arena-2010-09-07", "https://www.nasdaq.com/articles/bullish-arena-arna-trade-boosts-options-volume-2010-08-03", "https://www.nasdaq.com/articles/best-performing-small-cap-stocks-july-2010-where-are-they-headed-next-2010-07-28", "https://www.nasdaq.com/articles/3-stocks-watch-arena-pharmaceuticals-boeing-and-intermune-2010-12-21", "https://www.nasdaq.com/articles/tuesday-winners-vivus-ivanhoe-mines-and-brooks-automation-2010-07-13", "https://www.nasdaq.com/articles/monday-losers-acxiom-aon-corp-and-vivus-2010-07-12", "https://www.nasdaq.com/articles/arena-pharmaceuticals-rises-after-weight-loss-drug-deal-eisai-2010-07-05", "https://www.nasdaq.com/articles/friday-winners-thor-industries-arena-pharma-and-allergan-2010-07-02", "https://www.nasdaq.com/articles/thursday-winners-arena-pharma-christopher-banks-and-bjs-wholesale-2010-07-01", "https://www.nasdaq.com/articles/monday-winners-amylin-orexigen-and-polymet-minerals-2010-06-28", "https://www.nasdaq.com/articles/thursday-winners-arena-pharma-clean-energy-and-west-marine-2010-07-15"], "Content": []}